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Malignit kammioperaiset rytmihairiot, kuten kammiotakykardia ja kammiovarina,
ovat yleisimpia syita sydanperaiseen akkikuolemaan seka sairaalassa etta sen ul-
kopuolella. Sairaalassa kuten sen ulkopuolellakin tallaiset rytmihairiot ovat aina
hengenvaarallisia ja pitkittyessaan vahentynyt tai pysahtynyt hapenkuljetus eli-
mistoon pienentaa todennakoisyytta selviytya. Huolimatta viimeaikaisista ponnis-
teluista viiveettoman ja tehokkaamman elvytyksen eteen, sairaalassa tapahtuvien
sydankohtausten ennuste on pysynyt huonona. Tama johtuu lahinna viiveesta el-
vytyksen aloittamisessa ja monitoroinnin puutteesta, joten oleellisinta ennusteen
parantamisen kannalta olisi jatkuva rytmihairioriskin kvantitatiivinen arviointi
potilasmonitoroinnilla. Nain useat rytmihairiot voitaisiin estaa ja alkaviin voitai-
siin reagoida nopeammin. Nykyisin potilasmonitorointi on kuitenkin keskittynyt
jo alkaneiden rytmihairioiden tunnistamiseen eika ennustavia ratkaisuja ole tarjol-
la. Akillista sydankohtausta edeltavien ilmioiden tutkiminen ja rytmihairioriskin
maarittaminen kajoamattomalla potilasmonitoroinnilla ovat ensisijaisen tarkeita,
mikali rytmihairiopotilaiden ennustetta halutaan parantaa sairaalaymparistossa.
Tassa opinnaytteessa tutkitaan rytmihairioita edeltavia muutoksia EKG-
signaalista mitattavissa parametreissa eri potilasryhmissa ja yksittaisilla potilailla.
Esittelemme algoritmin, joka arvioi EKG.sta mitatuista parametreista yksittaisen
potilaan riskia rytmihairion kaynnistymiseen. Valitsemamme lahestymistapa poik-
keaa taysin olemassa olevista eika vastaavia tuloksia ole aikaisemmin julkaistu. Al-
goritmin kehityksessa hyodynnetaan laajasti olemassa olevaa tutkimustietoa ryt-
mihairioiden kaynnistymisesta ja yllapidosta. Olemassa olevat menetelmat on esi-
telty laajassa kirjallisuuskatsauksessa. Opinnaytetyon lopussa algoritmin kliinista
hyodyllisyytta ja tulevia kehitysnakymia on arvioitu saavutettujen tulosten valos-
sa.
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Malignant spontaneous ventricular arrhythmias, such as ventricular tachycardia
(VT) and ventricular brillation (VF), are the most common trigger of sudden
cardiac death (SCD) in and out of hospital. For a hospitalized patient, occurrence
of such arrhythmia is a struggle of life and death where every second of oxy-
gen deprivation, resulting from reduced blood ow, decreases chances of survival.
Despite recent advances in resuscitation strategies, survival rates in in-hospital
cardiac arrests remain unacceptably low. Main factors contributing to the poor
prognosis are lack of patient monitoring and delay in the initiation of resuscitation.
Thus, in order to increase the likelihood of successful resuscitation, or prevent the
arrhythmia from happening in the rst place, continuous and quantitative risk
of arrhythmia assessment is required. Currently, however, cardiac monitoring is
utilized to detect the onset of life threatening cardiac episodes only. Thus, de-
velopment of risk indices and the study of precursors of lethal arrhythmias have
great clinical value and will lead to better cardiac monitoring.
In this thesis, changes in ECG signal preceding lethal cardiac arrhythmias are
studied both in dierent patient groups and in individual patients. Furthermore,
an algorithm predicting imminent ventricular tachyarrhythmias is presented. Cur-
rent knowledge of underlying mechanisms of onset of ventricular arrhythmias is
used to assess the risk of arrhythmia continuously during cardiac monitoring of a
patient. Our approach is novel and similar assessment of such algorithm has not
been published previously. A review of existing methods and applications for risk
assessment of SCD with discussion of future trends and possibilities is also given.
Keywords: Electrocardiography (ECG), In-hospital sudden cardiac death, Ab-
normal repolarization, Predictive monitoring, Spontaneous ventricu-
lar tachyarrhythmias, T wave morphology
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Symbols and Abbreviations
Symbols
A Matrix
a Column vector
a Scalar
AT Matrix transpose
A 1 Matrix inverse
Ay Moore-Penrose pseudoinverse
jjajj2 Euclidean norm of a vector
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Abbreviations
ANS Autonomic nervous system
AMI Acute myocardial infarction
AP Angina pectoris
APD Action potential duration
AV Atrioventricular
ASY Asystole
CA Cardiopulmonary arrest
CAD Coronary artery disease
CCU Coronary care unit
CNS Central nervous system
CV Conduction velocity
DCM Dilated cardiomyopathy
FER Fitting error ratio
HCM Hypertrophic cardiomyopathy
HF Heart failure
HTR Heart rate turbulence
HRV Heart rate variability
ICD Implantable cardioverter debrillator
ICU Intensive care unit
IHCA In-hospital cardiopulmonary arrest
LTCA Life threatening cardiac arrhythmia
NPV Negative predictive value
OLC Optimal linear combination
OR Operating room
PPV Positive predictive value
PVC Premature ventricular complex
SA Sinoatrial
SCD Sudden cardiac death
TDP Torsade-de-pointes
TWA T wave alternans
VF Ventricular brillation
VT Ventricular tachycardia
VTA Ventricular tachyarrhythmia
WCD Wearable cardioverter debrillator
1 Introduction
Sudden cardiac death (SCD), i.e. death caused by abrupt failure of heart for some
reason, is a major cause of death in the industrialised western world. Malignant
spontaneous ventricular tachyarrhythmias (VTAs), such as ventricular tachycardia
(VT) and ventricular brillation (VF), are assumed to be the most common triggers
of sudden cardiac death [22]. In clinical setting, e.g. coronary care unit (CCU)
or intensive care unit (ICU), with electrocardiography (ECG) monitoring such ar-
rhythmias are diagnosed almost instantaneously and immediate actions are taken
to prevent arrhythmia from causing any further damage or SCD. In many cases,
however, preventive actions could be performed to prevent arrhythmia from occur-
ring if quantitative measure of risk of arrhythmia was available before the onset of
arrhythmia [69].
There are multiple scenarios in which short-term prediction could be a valuable
tool. For the hospitalized patients, identication of imminent arrhythmia could
lead to introduction of prophylactic techniques such as antiarrhythmic drugs and
prediction of a VTA would increase alertness of the sta decreasing the delay of
care and enabling administration of preventive medication. Decreased delay in the
initiation of cardiopulmonary resuscitation (CPR) could make a dramatic dierence
in the likelihood of survival for these patients [59, 75].
A major unanswered question in SCD is what is the immediate precipitating event
that causes the SCD at a specic time in an otherwise stable patient. Understanding
the trigger acting on the receptive substrate, which most likely may be dierent in
dierent patients and may involve very small changes in conduction, refractoriness,
and the like, is a major goal of SCD research [76]. Especially, multiple changes in
repolarization characteristics of the heart can be associated with risk of ventricular
arrhythmia and it is believed that changes in repolarization are the key in short-
term prediction of arrhythmias (see e.g. [72, 45, 38, 66, 65]). In this thesis ECG
parameters related to repolarization and their variability are studied, and their
usefulness in prediction of VTAs is discussed in detail.
Numerous recent studies have tried to identify parameters that change before an
imminent VTA episode with contradictory results. The focus in these studies has
been in trends averaged over all arrhythmia patients and little attention has been
paid to what happens before an event in individual patients. Thus, we introduce a
completely novel idea of predicting VTA episodes based on detection of specic fast
changes that are supposed to reect changes in the cardiac state of a patient. In
order to quantitatively evaluate the usefulness of dierent ECG parameters in VTA
prediction, an algorithm predicting imminent episodes is developed. The algorithm
is tested and predictive performance is assessed by using a data set of 61 patients (37
controls, 14 sustaine arrhythmias and 9 non-sustained). The database was recorded
at a coronary care unit (CCU). The database is divided into training and validation
sets in order to learn predictors of VTAs and conrm their usefulness. Based on our
results, it seems that predictive algorithm that achieves clinically useful sensitivity
and specicity could be achievable using parameters extracted from an ECG signal.
22 Background
The heart is an essential part of the human cardiovascular system providing all the
mechanical energy needed for the circulation. Should the heart fail in its vital task,
it would have fatal consequences. The failure can happen, for example, as a con-
sequence of malignant ventricular arrhythmias. Continuous evaluation of perform-
ance and condition of the heart is essential in clinical monitoring, e.g., in intensive
care unit (ICU) or coronary care unit (CCU). Among all the available methods for
cardiac monitoring, electrocardiography (ECG) is the most widely used due to its
relative ease of recording and analysing in a non-invasive manner.
In this chapter a short description of the heart and ECG are given. In addition, phe-
nomena underlying heart failure are discussed to justify the selection of parameters,
measuring risk of SCD explained in the next chapter.
2.1 Electrophysiology and the Heart
ECG is a non-invasive measure of electrical potential at the surface of the body.
Essentially, it measures the potential dierence between pairs of points on the body
as a function of time. The potential is generated by the myocardial cells in the heart.
To understand ECG one has to understand the depolarization and repolarization
cycle of a single cell, how the electrical activity is propagated and how synchronous
activity of all the cells in the heart produce measurable potential at the surface of
the body (i.e. forward model of ECG).
2.1.1 Heart and Cardiovascular System
The heart is located in the mediastinum, a mass of tissue that extends from the
sternum to the vertebral column between the lungs. It is surrounded by supportive
and protective membrane called pericardium. Pericardium is separated from the
outermost layer of the heart, epicardium, by the pericardial cavity containing liquid
that reduces friction as the heart beats. Majority of the heart's mass is comprised
of the myocardium (i.e cardiac muscle), that is responsible for the pumping action.
The myocardium is bounded by connective epi- and endocardium tissue layers that
are the outer and inner surfaces of the heart, respectively.
The heart has four chambers, two atria and two ventricles. Oxygenated blood
circulates from the lungs to the left atrium and through the mitral valve to the left
ventricle. The left ventricle ejects blood into the aorta. From the aorta, blood is
delivered to all organs throughout the body via arteries (except for the alveoli of
the lungs). Deoxygenated blood returns to the right atrium through the superior
and inferior vena cava and passes through the tricuspid valve to the right ventricle.
Then, blood passes through the pulmonary valve into the pulmonary trunk and
back to the lungs. The two atria are separated by the interatrial septum and the
ventricles by interventricular septum. In addition to cardiac muscle tissue, the heart
3wall includes a dense connective tissue that forms the brous skeleton of the heart.
The borous skeleton acts as an insulator between the atria and ventricles and forms
a structural foundation for the heart valves. The myocardium has its own network
of blood vessels, coronary circulation, that ensures nutrition and oxygen delivery
to the pumping heart muscle. See Fig. 1 for the illustration of the anatomy and
conduction system of the heart. [77]
Figure 1: Left: The anatomy of the heart. Right: The conduction system of the
heart and intrinsic excitation rates in dierent regions along the conduction system.
[39]
2.1.2 Electrophysiology of the Myocardial Cells
At rest, non-automatic myocardial cells have stable negative membrane potential.
For myocardial cells, cytosol is negatively charged with respect to the extracellular
uid so that the resting membrane potential is about -90 mV. The negative potential
is established and maintained by an active, i.e. energy consuming, exchange of
ions across the cell membrane in the direction of the concentration gradient. Ions
responsible for the resting membrane potential are sodium (Na+) and potassium
(K+). At rest sodium concentration is substantially greater outside of the cell than
in cytosol. The opposite applies for the potassium concentration. [30]
Action potential is a short-lasting event during which the electrical membrane po-
tential of a cell rapidly rises and falls. The action potential of non pacemaking
4Figure 2: Left: Five phases of cardiac action potential. Right: The propagation of
the action potential. The shape of the action potential in individual cells has distinct
characteristics in dierent regions of the heart.
myocardial cells has ve distinct phases (see Fig. 2). When the membrane poten-
tial is increased due to changes in the membrane potential of neighbouring cells,
the cell reaches a threshold level of approximately -65 mV which opens fast Na+
channels. The inux of positive Na+-ions is driven by an electro-chemical gradient
which depolarizes the cell rapidly ( 1-2 ms) to approximately +20 mV. The fast
depolarization, phase 0, is immediately followed by a rapid repolarization, phase 1.
The rapid repolarization is caused by the inactivation of Na+ channels and increased
permeability for K+-ions. The outow of positively charged potassium repolarizes
the cell. This outow, however, is active only for a very short period of time and
the cell remains polarized at the end of phase 1.
The third step (phase 2) is called the action potential plateau. The two dominant
currents are the inward calcium current and the delayed rectier potassium outward
current. The changes in membrane potential depend on the balance between in-
ward and outward currents and varies as a function of location in the myocardium.
Inactivation of the calcium channels leads to the end of the plateau. Since out-
ow of positive potassium-ions dominates, the cell repolarizes rapidly to the resting
potential (phase 3). At rest, phase 4, the cell membrane is permeable only to po-
tassium, thus the inward rectier potassium current is largely responsible for setting
the resting membrane potential.
Following the phase 0, there is a parallel set of cellular and molecular processes called
excitation-contraction coupling which links electrical functionality of a cardiac cell
to mechanic contraction. The triggering mechanism in this coupling is the inow
of calcium (Ca2+), which in turn unlocks the contraction mechanism of the cell
5(through a conformational change of the troponin protein complex) [10].
2.1.3 Propagation of the Action Potential
Once an action potential is initiated, it will propagate along the cell membrane until
the entire cell is depolarized. Furthermore, myocardial cells have unique property
of transmitting action potentials from cell to cell by means of direct electrical coup-
ling, called gap junction. These intercellular low-resistance connections allow direct
and fast change of ions between neighbouring cells. Thus, an impulse originating
anywhere in the myocardium will propagate throughout the heart, resulting in a
coordinated mechanical contraction.
A small portion of the cardiac cells make up a conduction system that is specialized
on fast transmission of electrical impulses. Ecient and coordinated pumping of the
myocardial muscle tissue is enabled by this specic conduction system that allows
fast propagation of electric impulse and coordinated contraction of the muscles.
These cells are autorhythmic and depolarize repeatedly and independently at cell
specic rate. Since the cells in the sinoatrial (SA) node, located in the right atrium,
possesses the fastest intrinsic rate of depolarization, each normal (sinus) beat is
initiated there. Also, the SA node, His bundle and Purkinje ber network contain
pacemaker cells. However, the SA node remains the dominant pacer due to fastest
intrinsic excitation frequency and phenomena called overdrive suppression [40].
From the SA node, the activation propagates through the atria along atrial muscle
bers and reaches the atrioventricular (AV) node. The AV node is located between
atria and ventricles and is the only location through which an action potential
enters the ventricles in a structurally normal heart. From the AV node the action
potential enters the bundle of His. From there the propagating action potential is
conducted through the right and left bundle branches to the Purkinje bers that
rapidly conduct the action potential to the ventricular myocardium. Depolarization
of the myocardial muscle cells is followed by a coordinated contraction leading to
ecient pumping of blood. After approximately 0.3 seconds from the depolarization,
cells repolarize and return to the resting state.
2.1.4 Electrocardiography
As a result of the electrical activity of the heart, measurable potential dierence is
established on the surface of the torso. An action potential propagating through
a single cell makes intracellular uid positively charged for the depolarized part
of the cell while rest of the cell remains negatively charged. The distribution and
movement of charged particles in the cell makes up a macroscopic (current) dipole.
Furthermore, since action potential spreads in the myocardium as a continuous wave
boundary [30], the surface corresponding to the boundary between depolarized and
polarized tissue may be represented by a layer of dipoles (see Figure 3). The vector
sum of these microscopic dipoles is called the heart vector and is an important
6concept in ECG analysis and interpretation.
At cell level, repolarization gives rise to a microscopic dipole with opposite polar-
ity compared to depolarization. Similarly to depolarization, repolarization can be
thought to make up a dynamic dipole layer. However, for repolarization, it is not
as straightforward because it is not a conduction phenomena. Since repolarization
is of special interest in this thesis, more detailed discussion is given below.
Direction of propagation
V_m(x,t)
A B
P
T
Figure 3: Left: Propagating action potential is a dipole. Right: Propagating action
potential in the heart can be modelled as a layer of current dipoles.
For a known current and charge distribution, geometry and conduction values of
the torso, potential at surface of the torso can be calculated by Maxwell's equations
[39]. In practise, however, certain approximation are usually made. Usually, the
torso is approximated as linear, isotropic and homogeneous conductor and quasi-
static approximation is supposed to hold for the Maxwell's equations. With these
simplifying assumptions the potential at the surface of the torso is given by the
Laplace's equation [39].
The normal electrocardiogram (Fig. 4 and 5), is a signal generated by a normal
heart without any conduction abnormalities or defects. The rst observable os-
cillation in ECG signal (the P wave) is a result of atrial depolarization. The P
wave is followed by an isoelectric period caused by a delay at the AV node. As
the wave of depolarization spreads to the septum, a small deection may be seen
(the Q wave) when the polarization wave propagates from left to right between the
ventricles. Subsequently, the wave of polarization spreads to the ventricles. The
ventricles polarize from endo- to epicardium. During the ventricular depolarization,
the direction of the heart vector is dominated by the left ventricle due to its bigger
size compared to the right ventricle. The depolarization of the left ventricle causes
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Figure 4: Intervals and wave names of the normal ECG.
greatest deection in ECG signal (the R and S waves). Ventricular depolarization
is followed by an isoelectric period, called ST segment, which results from the long
plateau period of the myocardial cells. Finally, the individual cells start to repol-
arize and another wave of charge passes through the heart. Normally, it appears
as if repolarization waves were propagating from epi- to endocardium with reversed
polarity compared to depolarization phase [39]. As a result, repolarization waves
(the T wave) on the ECG usually have the same polarity as depolarization waves.
Additionally, the U wave may appear after the T wave. Currently, it is known that
the U wave is a mechanoelectric phenomena but all the details underlying the U
wave are not known [54].
2.1.5 Ventricular Repolarization and T wave Morphology
The shape of the T wave is determined by the excitation sequence and the distribu-
tion of action potential duration (APD) in the myocardium. It is highly susceptible
to all kinds of inuences, both cardiac and non cardiac (e.g. hormonal, neurologic),
and is therefore highly variable in its appearance [13]. In clinical practise, investiga-
8Figure 5: The relation of normal ECG signal to the heart cycle. [39]
tion of the normalcy of repolarization is an important diagnostic tool. It is used, for
example, to diagnose ischemic heart disease and myocardial infarction [23]. Lately,
the idea that proarrhythmic changes in the cardiac cells are seen on the T wave
of ECG has gained increased interest among researchers (see e.g. [81, 83]). This
intriguing idea is also under investigation in this thesis.
If all the cells in the heart had identical action potential the wave of repolarization
would just follow the wave of depolarization. However, this is not the case. Unlike
depolarization, repolarization is not a propagating phenomenon. Instead, repolar-
ization occurs in each cell after the plateau phase, the duration of which is not
homogenous throughout the myocardium and is not necessarily the same in neigh-
bouring cells. Of course, the myocardial cells located in the same area are likely to
have approximately similar repolarization characteristics. As a consequence, it may
seem that repolarization propagates from cell to cell like depolarization. [39]
In a healthy heart, measurable repolarization signal can be approximated to arise
from a propagating dipole layer with reversed polarity compared to depolarization.
However, with certain pathologies, the cell level properties of repolarization may be
altered locally resulting to discontinuous "wave propagation". The local changes are
9also seen on surface ECG since the T wave morphology is believed to be determined
by the dierences in the action potential morphology and synchronization in dierent
anatomical regions of the ventricles. [39]
Phenomena underlying the changes in the morphology of the T wave may be cat-
egorized as primary and secondary repolarization abnormalities [54]. Abnormalities
in the ST segment and T wave, which are the result of changes in the shape and/or
duration of the repolarization phases of the transmembrane action potential and
occur in the absence of changes in depolarization, are called the primary repolariz-
ation abnormalities. Conversely, abnormalities in the ST segment and T wave that
occur as a direct result of changes in the sequence and/or duration of ventricular de-
polarization, manifested electrocardiographically as changes in QRS complex shape
and/or duration, are referred to as the secondary repolarization abnormalities. In
other words, the secondary changes do not require changes in the shape or dura-
tion of phases 2 and 3 of ventricular action potential of individual cells but primary
changes do. If an investigator is interested to track the changes of action potentials
of the cells, like in this thesis, distinction between the two types of abnormalities is
essential.
Primary changes may be localized or diuse and may be caused by variety of events
which may be arrhythmogenic. These include ischemia, myocarditis, drugs, toxins,
and electrolyte abnormalities, particularly abnormalities of serum calcium and po-
tassium concentration. In addition, an abrupt change in heart rate, sympathetic
stimulation and change in the body position can also cause primary repolarization
abnormalities. Secondary repolarization abnormalities appear when changes in de-
polarization sequence alter the repolarization sequence. Conduction blocks, such
as left and right bundle-branch block (LBBB and RBBB), premature ventricular
contraction (PVC), and paced ventricular complexes are examples of secondary re-
polarization abnormalities. [54]
As heart rate changes, both primary and secondary repolarization abnormalities
take place. Increased heart rate shortens action potential duration (APD) and
repolarization time of individual cells (primary). Additionally, conduction properties
change as a function of heart rate, which results to secondary repolarization changes
[13]. Conditions causing the primary changes can also aect conduction properties
and change the depolarization properties. Thus, the two repolarization alterations
are commonly seen concurrently and cannot always be separated. Consequently,
one can classify a repolarization change to be primary with any certainty only in
the complete absence of depolarization changes.
2.1.6 Measurement of ECG
The electrocardiogram is a measure of the potential dierence between electrodes
attached to the surface of the body. In principle, the potential is measurable from
arbitrary body positions. However, to standardise the measurement, only certain
lead congurations are used. The most common measurement conguration is the
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12-lead ECG system (or subset of it), which is also used to obtain the data in this
thesis. Other commonly used lead congurations, such as, the vectocardiographic
lead system and more complicated system are not used nor described in this thesis.
For more detailed information of alternative ECG lead systems, see e.g. [39] and
[23].
The rst clinically important ECG measuring system was used in 1908 by Einthoven
[39]. The Einthoven limb leads are still part of the modern 12-lead ECG system.
They are dened as potential dierences between arms and left foot. In particular,
lead I is the dierence between left and right arms, lead II is the dierence between
left foot and right arm and, nally, lead III is the dierence between left foot and left
arm, see Fig. 6. The three limb leads are used to dene the so-called Wilson central
terminal. The Wilson central terminal is formed by connecting a resistor from each
terminal of the limb leads to a common point. The potential dierences between the
central terminal and body extremities are used to get more signals. The so-called
augmented leads aVL, aVF and aVR are formed by linear combinations of potentials
at the body extremities. Furthermore, six electrodes are placed around the torso in
the horizontal plane. The precordial leads, V1-V6, are potential dierences between
the chest leads and the central terminal, see Fig. 6. Note that there are only 8
independent signals in the standard 12-lead system since only two of the leads I- III
are independent and the augmented leads are fully redundant with respect to the
limb leads. [39]
To understand the link between the heart vector, resulting from the cell level cardiac
activity, and surface potential (i.e. ECG) the following simplications are usually
made: the source is thought to be purely dipolar, the body is approximated as a
linear, isotropic, homogenous, and spherical conductor. The source is modelled as
a slowly time-varying single current dipole located at the center of the spherical
conductor. In addition, the quasi-static approximation to Maxwell's equations is
assumed to hold. Thus, the static electric eld, current density, and electric poten-
tial everywhere are non-dynamically related to the heart vector. In this simplied
forward model, it can be shown that signals in the leads are projections of the heart
vector to predened angles (see Fig. 7). [10, 39]
2.1.7 Autonomic Nervous System { The Role of Regulation
Without any external inuences the SA node would initiate a heart beat about
100 times per minute. However, the consumption of oxygen and nutrients vary as
function of activity of the body and cardiac output must be regulated accordingly.
The most important regulator of the heart is the autonomic nervous system (ANS)
via signalling transmitter molecules and chemical modulation via hormones. Several
experimental and clinical observations support the observation that the ANS and
the neurohuomoral signalling have a role in the genesis of fatal cardiac arrhythmias
[37].
The center of cardiac modulation is located in the medulla oblongata in the brain
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Figure 6: Left: The positions of the limb leads. Right: The positions of the
precordial leads. [39]
stem and the hypothalamus. The cardiovascular center receives aerent connections
from a variety of sensory receptors, such as chemoreseptors and baroreceptors, and
from higher brain areas and has eerent neuronal connections to various parts of the
heart (see Figure 8). The innervation can be divided into the sympathetic and the
parasympathetic branches which are the two compelling components of the ANS.
[77]
The sympathetic eerent neurons innervate the SA node, AV node and the most part
of the myocardium (see Fig. 8). Activation of these neurons releases norepinephrine
which increases the ring rate of the SA node, increases the propagation speed
of the depolarization wavefront through the AV node and increases the strength
of contraction in the atria and ventricles. The sympathetic neurons innervate the
adrenal gland, which releases adrenaline in blood. Parasympathetic nervous system
modulates the heart via the vagus nerve. It innervates the SA and AV nodes and,
when activated, releases acetylcholine. Conversely to the sympathetic branch, the
parasympathetic nerve impulses decrease the ring rate of the SA node and decrease
action potential propagation through the AV node. The two branches of cardiac ANS
operate at dierent time-scales { parasympathetic changes take eect in orders of a
few seconds, while for the sympathetic branch it takes up to 15 seconds to accelerate
the cardiac functions. [77]
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Figure 7: Left: Projection angles of frontal plane limb leads. Right: Projection
angles of transverse plane. [39]
2.2 Ventricular Arrhythmias and Sudden Cardiac Death
Cardiovascular diseases are the single most common cause of natural death in the
developed nations. SCD is estimated to account for approximately 50 percent of
these deaths. Due to the enormous and incalculable socioeconomic burden [70],
researchers' eorts to uncover the underlying mechanisms, identify the people who
are at high risk, and develop methods to decrease the incidence of SCD have been
substantial. In the context of this thesis, only the onset and the last 48-24 hours
before SCD is under investigation.
Ventricular arrhythmias are thought to be the most common primary cause of SCD.
The onset and maintenance mechanisms of these arrhythmias are well studied but
poorly understood processes. It is known, that ventricular arrhythmias hardly ever
occur in a healthy heart. In majority of the cases an underlying cardiac disease
can be found, which causes a heart failure (HF), i.e. a medical condition dened
as inability of the heart to supply sucient blood ow to meet the body's needs.
Various cardiac diseases, however, change the cardiac function dierently. [76, 25,
56, 58]
2.2.1 Time Scale and Risk of Sudden Cardiac Death
For majority of the SCD occurrences, death is the rst and last manifestation of
the underlying cardiac illness. However, this does not mean that the illness itself
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Figure 8: The center of cardiac modulation receives aerent connections from various
sensory receptors and from higher brain areas. The parasympathetic and sympathetic
branches innervate the SA node, AV node and myocardium enabling the control of
cardiac output.
develops rapidly. On the contrary, it may take years or decades for the disease to
advance with complex processes where the way of life and genome have an important
role [22].
Only 5 { 10 % of the SCD can not be explained to be caused by a disease. Thus,
for approximately 90 {95 %, a cardiac disease, such as coronary disease, infarct or
cardiomyopathy, and its eect on the cardiovascular system are said to make up a
substrate for the SCD. The risk of SCD is increased by the substrate but to destabil-
ize the heart the cardiac state must be altered by some "exposing factor". These
factors aect usually in the time-scale of days to hours and include e.g. transient
ischaemia, electrolyte disturbances, neurocardiovascular inuences, and hemody-
namic uctuations. Particularly, acute myocardial ischemia is considered to be the
most common factor triggering fatal arrhythmias [25]. In addition, sometimes a
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triggering event, such as premature ventricular contractions (PVCs), are present
which onsets a malignant cardiac event such as an arrhythmia. The division to
these dierent time-scales and corresponding agents is illustrated in Fig. 9. [22]
In this viewpoint spontaneous occurrence of ventricular tachyarrhythmia VTA may
be regarded as a stochastic event that arises from complex interactions between
relatively xed anatomic and functional substrates and transient triggering event.
In this thesis proarrhythmic factors that alter the cardiac state minutes to hours
before arrhythmias are investigated. Some of these are discussed with details below
in section 2.2.6.
Trigger
PVC
Atrial arrhythmias
Alteration
Ischaemia
Electrolyte disturbance
Poisoning
Bigeminy
Substrate
Coronary artery disease
Cardiomyopathy
Infarct
Structural abnormalities, genetic predisposition
Years Days to Hours Minutes to Seconds
Figure 9: Three levels of assessing the of risk of sudden cardiac death with dierent
time scales.
2.2.2 SCD in General and Specic Populations
The most important unanswered question in the study of SCD is: who is prone
to it. Eective measures of increased risk of SCD have been found for specic
patient populations but not for general population [22, 70]. The problem is that
majority of the SCDs occur among patients who do not have any symptoms before
the occurrence. In this general population, incidence of SCD is only about 1/1000
per year [25]. Thus, it is almost impossible to identify high-risk cases from this
population where death is the rst and last manifestation of the underlying cardiac
illness. See Fig. 10 for illustration and more details.
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Figure 10: The incidence of SCD in specic populations and annual numbers of
sudden deaths in these populations. [25]
2.2.3 Classication of Ventricular Arrhythmias
Cardiac arrhythmias exist in various forms and underlying mechanisms. Some of
them may be relatively harmless, like atrial and junctional arrhythmias, whereas
others, such as ventricular brillation, are life threatening [22]. In this thesis, we
are only interested on malignant arrhythmias that are caused by short-term time
varying changes in the cardiac state. These include ventricular tachycardia (VT),
ventricular brillation (VF) and asystole (ASY).
In ventricular arrhythmias the electrical activation does not originate from the AV
node and/or does not propagate in the ventricles the normal way. If a single beat
originates from ventricles prematurely early during a sinus rhythm it is called a
premature ventricular contraction (PVC). PVCs usually have wider QRS complexes
due to abnormal conduction. If PVC and supraventricular (i.e. SA node triggered)
beats alternate so that every other is of ventricular origin the rhythm is called
bigeminy. [9]
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Figure 11: Examples of ventricular arrhythmias. A: Premature ventricular con-
traction (PVC). B: Ventricular tachycardia (VT). C: Ventricular brillation (VF).
Ventricular tachycardia (VT) is a fast rhythm of more than 3 consecutive beats
originating from the ventricles at rate more than 100 beats per minute [9]. VT that
lasts longer than 30 seconds is called sustained. Furthermore, monomorphic VT has
only one repeating QRS morphology, whereas polymorphic VT exist with multiple
morphologies and beat origins. Torsade-de-pointes (TDP) is a special form of VT
which is characterized by irregular rates of 200-250/min with marked variability in
amplitude and direction of the QRS wave that seems to twist around the isoelec-
tric baseline. TDP is closely related to prolonged QT interval [22]. Ventricular
brillation (VF) is a rhythm characterized by chaotic activation of ventricles. The
ECG signal recorded during a VF is typically undulation without identiable QRS
complexes. VF causes immediate cessation of blood circulation and degenerates
further into pulseless electrical activity or asystole, a at ECG indicating no cardiac
electrical activity. See Fig. 11 for illustration of dierent rhythms.
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2.2.4 Mechanisms of Ventricular Arrhythmias
The ultimate cause of ventricular arrhythmias is a critical alteration in the electrical
properties of the myocytes. The four known arrhythmogenic mechanisms are altered
automaticity, triggered activity, sodium dependent reentry, and calcium dependent
reentry [40]. These mechanisms are illustrated in Fig. 12.
Altered abnormal automaticity is caused by altered phase 4 depolarization. This
kind of automaticity is a property of all pathologically depressed myocardial cells
making them to act as pacemakers. Consequently, abnormal automaticity may
trigger an action potential virtually anywhere in the heart. Altered automaticity
causes, for example PVCs and both junctional and ventricular tachycardias. Note,
that automaticity that causes ventricular escape beats (i.e. normal automaticity),
for example, is a normal property of cardiac cells of the conduction system. [40, 9]
Accessory
pathway
AV node
Refractory tissue
Partially refractory tissue
Fully excitable tissue
Increased automaticity Triggered activity Reentry
-65
Threshold
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Abnormal phase 4 repolarization
Normal phase 4 repolarization
Early afterdepolarization
A B C
0
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0
-90
D E
1000 ms 750 ms
Late afterdepolarization
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B
C
Reentrant circuit defined by anatomy
Reentrant circuit defined by 
tissue refractoriness
Reentrant circuit defined by 
tissue conduction properties
Figure 12: The main mechanisms behind ventricular arrhythmias. Increased auto-
maticity: resting potential increases during phase 4 triggering action potential in
a normally nonautomatic cell. Triggered activity: Early afterdepolarization is
an upward oscillation of the membrane potential during phase 2 causing no action
triggered impulses (A), one extra impulse (B) or series of triggered impulses (C).
Late afterdepolarization causes an abnormal upstroke of membrane potential dur-
ing phase 3 causing no triggered activity during lower heart rate (D) and series of
triggered activity during higher stimulus rate (E). Reentry: Reentry circuit can be
facilitated by anatomy (A) tissue refractoriness (B) or tissue conduction properties
(C). [9]
Depolarization of a cell membrane abnormally after or during repolarization (phase
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3 of action potential) is called delayed afterdepolarization (DAD) or early afterdepol-
arization (EAD). If the afterdepolarization reaches a threshold potential, it triggers
an action potential, which may propagate to the surrounding cardiac cells causing
the whole heart to depolarize abnormally [9]. Both EAD and DAD are related to
abnormal repolarization. For example, TDP is thought to be caused by EAD and
DAD is thought to cause some forms of VT [40].
Re-entry is a conduction process, where an impulse propagates through a tissue
already depolarized by the same impulse. Furthermore, re-entry is circulatory move-
ment around an obstacle, that can be anatomic or functional, leading to repetitive
excitation at a frequency that depends on the conduction velocity of the impulse
and the dimensions of the obstacle. In addition to the circuit, an unidirectional
block and the presence of slow conduction are needed for re-entrant arrhythmia to
take place. In fact, the great majority of clinical tachycardias have a re-entrant
mechanism. Clinical tachycardias are caused by abnormalities in propagation of the
electrical impulse through cardiac tissue rather than abnormalities in activation of
individual cells [9].
Anatomical re-entry may be established on congenital circulatory pathways, like
Wolf-Parkinson-White syndrome (WPW), or acquired anatomical obstacles, such
as scar resulting from a myocardial infarct. Conversely, functional re-entry occurs
in the absence of a predetermined structural circuit [9]. It is postulated that the
functional re-entry occurs as a propagating wave turns back on its own refractory
tail [40]. It is also suggested, that spiralling wave, causing ventricular brillation,
may maintain themselves through re-entrant mechanisms [9].
2.2.5 Diseases Behind Sudden Cardiac Death
Coronary artery disease (CAD) or atherosclerotic heart disease is the end result of
the accumulation of atheromatous plaques within the walls of the coronary arteries
that supply the myocardium with oxygen and nutrients. CAD is found to be the
most common cause of sudden cardiac death (SCD) accounting for approx. 80 %
of the cases [22]. In addition to lethal arrhythmias, CAD can cause the death by
rupture, hemorrhage and thrombosis. Most often, CAD causes ischemic heart dis-
ease that is known to cause arrhythmias by two mechanisms: VT triggered by acute
myocardial ischemia with or without preexisting myocardial scarring and VT re-
lated to anatomical substrate from previous infarction without active ischemia [25].
Another major disease behind SCD is the cardiomyopathy, which causes gradual
deterioration of the function of the myocardium. Dilated and hypertrophic cardi-
omyopathies account for approx. 10{15 % of the cases. In addition, various un-
common causes, such as congenital heart disease and known genetically determined
ion channel anomalies [56], e.g., Brugada and long-QT syndrome, are responsible
for the remaining 5 % of the cases. These rare congenital diseases are well studied
and documented in literature and will not be studied in this thesis. Although the
risk factors behind these diseases are known, it is unclear how to assess the risk of
arrhythmias caused by these diseases. [25]
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Arrhythmias are thought to cause vast majority of SCDs. However, there is usually
no specic anatomic pathology of sudden cardiac death [58]. The only reliable way
of diagnosing cardiac rhythm is ECG. Thus, statistics are based on ECG recordings
of hospitalized patients suering SCD and generalization to SCDs occurring out of
hospital is uncertain [22].The most common arrhythmic event causing SCD (63 %)
is ventricular tachycardia (VT) degenerating to ventricular brillation (VF) and,
later, to asystole, see Fig. 13. Dierent forms of bradyarrhythmias, particularly in
patients with advanced heart disease, make up the second largest primary cause of
SCD accounting for 17 % of the cases [25]). Furthermore, torsade-de-pointes (TDP)
is the cause of SCD in 13 % and primary VF is the cause of SCD in 7 % of the cases.
[22]
 Uncommon causes
 Cardiomyopathy
 CAD
 VF
 TDP
 Bradyarrhythmias
 VT->VF
Figure 13: Left: Diseases behind SCD. Right: Cardiac arrhythmias behind SCD.
[25]
2.2.6 Arrhythmogenic Mechanisms in Heart Failure
Advancing heart failure (HF) causes substantial changes in the heart, spanning from
cell/molecular to organ-system levels [31]. These changes promote the prolongation
of the action potential, the enhancement of spatio-temporal gradients of repolar-
ization, the formation of calcium-mediated triggers and conduction abnormalities,
all of which combine to form an electrophysiological substrate that is ripe for the
genesis of lethal arrhythmias and sudden cardiac death. Although increased trans-
mural dispersion of repolarization is suggested as potential unifying mechanism for
arrhythmias associated with various diseases, it is unclear whether these changes
are directly linked to the onset of arrhythmias [31].
Myocardial ischemia alters both active and passive conduction properties of the
heart [8]. The former occurs between 5 and 7 minutes after arrest of myocardial
perfusion and is manifested as a change in ion transportation properties across the
cell membrane. In particular, the fast depolarizing sodium current is reduced and
the resting potential becomes less negative [40]. The latter occurs between 20 and 30
minutes after the arrest of perfusion and is manifested as decoupling of the myocar-
dial cells, i.e. the amount of inter-cell gap junctions decrease. All of these changes
lead to increased electrical resistivity and decreased conduction velocity, which is
sometimes observed in ischemia triggered arrhythmias [8]. Further degeneration of
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conduction properties will eventually lead to a conduction block, which is a pre-
requisite for a reentrant arrhythmia [40, 2]. In fact, decreased conduction velocity
is documented as a general property of a failing ventricle [31]. The decrease in the
conduction velocity (CV) is seen as a widening of the QRS complex.
Changes in ionic currents during ischemia are not restricted to the depolarization
phase. In fact, both plateau and repolarization phases are very sensitive to changes
in the cardiac state [56]. Prolonged action potential duration (APD) is a common
nding in a failing heart and is seen as a prolongation of the QT interval in the
surface ECG [31]. The three key changes behind the changes are a downregulation
of repolarizing potassium current, an increase in late Na+ current and changes in
intracellular calsium (Ca2+) handling [31]. In addition, these changes occur hetero-
geneously in dierent cardiac cell layers aecting mid-myocardial and endocardial
muscle layers more than the epicardium, which increases repolarization heterogen-
eity [2].
Increased abnormal automaticity and triggered activity are well documented phe-
nomena in a failing heart. They act as triggers of arrhythmia in a vulnerable tis-
sue substrate [2]. Especially, intracellular calcium (Ca2+) cycling abnormalities are
thought to be responsible for multiple arrhythmogenic changes, such as early and
late afterdepolarizations and extraction-contraction decoupling [56, 61]. Abnormal
calcium handling may cause beat by beat alternation in action potential duration
(APD) that can be seen as T wave alternans in the surface ECG [66].
Cardiac diseases, such as ischemic heart disease and cardiomyopathies, cause rein-
nervation of the heart and, in autopsy specimen, an increased density and spa-
tial heterogeneity of sympathetic nerves were associated with previous history of
ventricular tachyarrhythmia (VTA) [76]. Consequently, increased sympathetic tone
is likely to increase transmural dispersion of repolarization and regional heterogen-
eity of the other electrophysiological properties, such as action potential duration
and conduction properties, in a failing heart [31].
2.2.7 In-hospital Cardiopulmonary Arrest and Sudden Cardiac Death
The application area of the predictive algorithm described in this thesis is cardiac
monitoring. Thus, it is useful to review the need and applicability of the algorithm
in real clinical settings. The questions addressed will be the following: What is the
meaning of time and monitoring in cardiac resuscitation? Who would benet from
the predictive algorithm? How much earlier the prediction would be needed to be
useful? How the anticipatory data would change the way we treat the in-hospital
cardiopulmonary arrests (IHCAs)?
Currently, the resuscitation guideline to treat IHCA is described by the concept of
"chain of survival", which includes early recognition, cardiopulmonary resuscitation
(CPR), debrillation and advanced care [49, 48]. Despite wide-spread appliance of
the concept, the IHCA mortality remains unacceptably high, around 80 % [33, 50].
Multiple factors, such as the rst monitored rhythm, the delay before initiation of
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Figure 14: Percentage of patients and probability of survival as a function of time
delay from the onset of VTA to the beginning of CPR. Probability of survival de-
creases by 7-10% with every minute of delay [53]. (Image not in scale)
CPR and the unit where the patient is admitted, aect the survival rate substantially
[60].
Cardiac arrhythmia is classied into "shockable" versus "non-shockable", based on
the underlying rhythm. The two shockable rhythms are ventricular brillation and
ventricular tachycardia while the two non-shockable rhythms are asystole and pulse-
less electrical activity (PEA) [50]. This division refers to whether particular class of
arrhythmia is treatable using debrillation. It has been reported that about in 25{
30 % of IHCAs the rst documented rhythm is VF/VT, PEA and asystole account
for 35 % each [33]. The statistics are found to be the same between heart failure
(HF) and non-HF patients [50]. Thus, only one third of the cardiac arrests (CAs)
are caused by a shockable arrhythmia. The likelihood of survival is substantially
higher for shockable rhythms than for other arrhythmias. Survival rates range from
18 % to 64 % for VF/VT and from 1.2 % to 14 % for non-shockable rhythms [60].
The time from the onset of IHCA to the beginning of CPR is found to be a crit-
ical predictor of survival in multiple studies [60]. The only eective treatment for
ventricular brillation is prompt debrillation, as the probability of survival de-
creases by 7-10 % with every minute of delay [22, 68]. Resuscitation guidelines
suggest that emergency care for cardiac arrest should include debrillation within 3
minutes in a hospital setting, and within 5 minutes elsewhere. Furthermore, Spear-
point et al. claim that CPR should be initiated within 1 or 2 min [71]. Consequently,
patients suering an IHCA in the ICU or CCU present a better prognosis despite
their more severe underlying conditions [59] and it may be assumed that patients
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may die unnecessarily due to sudden cardiac arrest if proper in-hospital resuscitation
programmes are not available [18]. The dierence in the location dependent survival
rates can be explained by alertness of the sta, cardiac and other monitoring [75] of
the patients and the higher proportion of shockable rhythms in ICU/CCU [60].
Two main patient groups that would benet from the predictive algorithm can be
distinguished. The groups are set apart by the rst monitored rhythm, location,
whether the cause of arrhythmia is primarily heart related, time course and progres-
sion of deterioration [48]. The rst group is usually located in a monitored area in
the hospital (such as ICU/CCU), the onset of CA is caused primarily by a cardiac
cause, usually ischemia, deterioration is likely to be fast and the rst monitored
rhythm is VT/VF that can be debrillated fairly often and the patient is likely to
discharge alive. In comparison, the patients in the second group are usually located
in a general ward, not actively monitored and a slow non-cardiac physiological de-
terioration leads to cardiac arrest with the underlying rhythms of PEA/ASY with
very poor chance of survival to hospital discharge. Since IHCA is more likely to be
avoidable in the non-cardiac group and CPR is more likely to succeed in the cardiac
group [24], dierent strategies are needed when handling and preventing IHCA in
these groups. Majority of the IHCAs are non shockable thus for these prevention
would be the only way to increase likelihood of survival substantially. For shockable
rhythms, both shorter delay to debrillation and prevention would lead to better
results.
The reported incidence of IHCA is relatively low, 0.175 events/bed annually in-
cluding all hospital areas [60] or in-hospital incidence of attempted CPR of 0.0591
attempts/bed per year [68].
Incidence of in-hospital VT/VF is dicult to estimate. Some studies estimate that
the incidence among VT/VF patients is around 1-5 % [29]. In selected in-hospital
cohorts comprising high percentage of patients with cardiac ischemia, the prevalence
of VF/VT is high and exceeds 50 % [60]. Consequently, CCU patient selection
criteria have signicant eect on the incidence rate.
2.2.8 Prediction of In-Hospital Cardiac Arrest
Despite recent advances in the understanding of the pathophysiological mechanisms
leading to cardiac arrest, and considerable eorts to spread the knowledge of ba-
sic life support (BLS), the mortality of patients with cardiac arrest remains high
and many survivors suer from devastating neurological sequelae. Most in-hospital
cardiac arrests are preceded by events that often go overlooked and whose correct
interpretation could be associated with a reduced mortality rate. However, because
many factors can delay cardiopulmonary resuscitation (CPR), it appears that the
prevention rather than the treatment of cardiac arrest would be a major factor in
reducing the subsequent heavy burden of death and disabilities [7]. Since only a
minority of IHCA patients survive and failed resuscitations consume substantial
healthcare resources and identication of potential survivors from pre-arrest factors
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is very complicated [33], the prevention would be highly desirable.
Independent investigators have demonstrated that in many instances cardiac arrest
occurring in a theoretically protected environment such as a hospital cannot really be
considered sudden and unexpected because it can be preceded by anticipating events,
which, in a post-hoc analysis, could be regarded as warning signs [7]. Evidence
of deterioration during the 8 h before the arrest has been reported in up to 84
% of cases, the most common ndings being respiratory problems, deterioration of
mental status and haemodynamic instability [60]. In addition, Berlot et al. reported
that in 86.4 % of patients the nurse or medical records reported the appearance
of new symptoms or the deterioration of the underlying condition during the 6 h
preceding the cardiac arrest [7]. Another recent study identied failing respiratory,
cardiovascular, and nervous systems and abnormalities of heart rate, blood pressure,
respiratory rate, and conscious level as a common signs that precede IHCA [49].
In many cases, it is not clear if the IHCA simply represents the biologic conclusion
of the patients aected by multiple severe underlying diseases or a truly unexpected
event that, if successfully prevented, might not have caused the death of the sub-
ject [7]. However, potentially 61.9 % of IHCAs are avoidable and the likelihood for
potentially avoidable cardiac arrest is estimated to be higher for patients in general
ward than in critical care areas ( 77.8 % and 40.5 %, respectively ) [24]. Poten-
tially reversible causes for cardiac arrest include hypovolemia, hypoxia, electrolyte
disturbance, particularly hyper- or hypokalemia, acidosis, tension pneumothorax,
cardiac tamponade, acute coronary syndrome, pulmonary embolus, hypothermia
or poisoning [84]. Even when cardiac arrest is unavoidable, predictive algorithm is
useful since it reduces the delay to the onset of CPR or debrillation. This would in-
crease, for example, the prognosis of patient with acute myocardial infarction since
of those patients that survive debrillation of VF to hospital discharge, one-year
mortality is not increased compared to patients with uncomplicated infarcts [9] and
early debrillation increases the likelihood of the discharge.
From the above, it is clear that in most cases an in-hospital sudden and unexpected
death is neither sudden nor unexpected. The current policy of training hospital
professionals CPR and early debrillation does not even consider that IHCA can
be foreseen and in many cases prevented. Observers have suggested that avoid-
able arrest results from a failure to act on clinical information rather than a lack
of information. Problems include information gaps and delay between nurses and
doctors, inexperience and lack of education, failure in monitoring oxygen saturation
and respiratory rate losses [24]. These problems could be tackled by increased auto-
mated monitoring of high risk patients. Monitoring of basic biosignals should be
possible and cost-eective beyond critical care areas and should be promoted as a
part of systemic approach to the prevention of in-hospital cardiac arrests.
An interesting question is, could ECG be used to monitor anticipatory events beyond
electrical activity of the heart. For example, respiratory and function and tone of
autonomic nervous system (ANS) can be monitored from ECG signal [10]. Thus,
it is obvious that patients in the general ward would also benet from (cardiac)
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monitoring, which would increase the usability of monitoring beyond ICU and CCU.
However, as not all important vital signs are, or can be, monitored continuously in
general ward areas, the ability of these systems to predict cardiac arrest remains
unconrmed [48].
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3 Review of Risk Assessment of Ventricular Ta-
chyarrhythmias
Mechanism of ventricular tachyarrhythmias (VTAs), i.e. what makes an arrhyth-
mogenic substrate (see the previous chapter), are known and well studied. The
onset, however, is the mystery. It may be assumed, if the onset is not random, that
mechanoelectric properties of the myocardium are altered prior to the onset. These
changes may be measurable or small and invisible in surface ECG or occur too slowly
to be detected. The assumption in this thesis, however, is that some arrhythmias
are preceded by a transient change in the heart and that they are measurable with
surface electrodes.
In recent years, the focus of research has been on discovering prognostic parameters
that discriminate SCD cases from a high-risk population in follow-up studies. These
studies have demonstrated relatively good predictive performance among some pa-
tient groups [37, 27, 51, 25, 12]. Advances in measurement and storing of ECG
signals have enabled recording of long high resolution ECG signals prior to VTAs,
which makes it possible to investigate mechanism responsible for the onset of VTAs.
In this chapter, ECG parameters and methods, used for short-term prediction are
reviewed.
3.1 Morphology Related Parameters
Majority of the arrhythmogenic changes in the cardiac state, such as ischemia [38]
and drugs [4], manifest themselves as changes in the repolarization phase of indi-
vidual myocardial cells. This may be observed as a change of the morphology of the T
wave. Especially, optical action potential mapping and patch clamp techniques have
identied changes in the early and late phases of repolarization in failing hearts [2].
QT interval prolongation is a well studied parameter (see e.g. [35]), mostly because
of its relation to the long QT syndrome and Torsade-de-pointes (TDP). Recently,
also the change of the shape [32] and amplitude oscillations [20, 47] of the T wave
have been found to have a prognostic value. These parameters are thought to reect
spatio-temporal repolarization heterogeneity or altered repolarization sequence and
instability, which are known to cause arrhythmias [37, 2].
3.1.1 T Wave Morphology
Atypical T wave morphology may reect abnormalities of the ventricular repolar-
ization process and mean, for example, increased repolarization heterogeneity, i.e.
dispersed spatial distribution of repolarization, in the myocardium. However, the
link between these abnormalities and the onset of VTAs is unclear [31]. Changes
in T wave morphology prior to the onset of VTA are relatively poorly studied.
Existing research is limited to drug induced eects and invasively measured data
using implantable cardioverter debrillators (ICDs). Recent computer simulations
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of repolarization have demonstrated the exploitability of T wave morphology as
a measure of repolarization sequence [14], ventricular repolarization heterogeneity
[78, 81] and specic ion channel properties [82].
Xue et al. have studied a set of new T wave morphology parameters as an improve-
ment to cardiac safety trials currently relying on QT interval measurements only [4].
The parameters are targeted to detect changes caused by the fast potassium current
IKr that is the most common factor behind drug induced repolarization changes and
arrhythmias [3, 82]. The T wave morphology parameters, symmetry, atness, and
notch, are described b Xue et al. in [83]. In addition, certain antiarrhythmic [32] and
antidepressant [67] drugs are known to predispose to malignant VTAs. Kurokawa et
al. [32] studied the eect of antiarrhythmic drug bepridil on T wave morphology in a
recent follow-up study that tried to identify distinguishing TU-morphology changes
that predispose to VTA episodes. After multivariate analysis, the only dierenti-
ating parameter studied was increased proportion of negative T waves. All these
studies suggest that T wave morphology is an important feature when assessing the
risk of drug induced arrhythmia. However, meaningful measurement of these para-
meters presuppose stable state during the measurement. Thus, they are not useful,
for example, during acute myocardial ischemia due to substantial ST changes and
non-stationarity [54, 38].
Maury et al. [42] studied T wave morphology prior to the onset of VTA using
intracardiac electrocardiograms stored in ICDs. The group investigated eleven mor-
phology parameters prior to the onset and compared these to control recordings
sharing comparable QRS and T wave morphology and similar heart rate in the
same patient. Signicant dierences were found only in T wave amplitude (higher
before VTAs) and slopes (steeper before VTAs). Durations and timings of the dif-
ferent parts of the T wave did not change signicantly. This study implicates that
T wave amplitude and slope related parameters could also demonstrate changes in
surface ECG prior to VTA onset. Shusterman et al. [65], in contrast, found that
the peak and the mean amplitude of the T wave, as well as the area under the T
wave, did not show a statistically signicant change before an onset.
The most signicant conceptual challenges in using T wave morphology parameters
for short-term arrhythmia prediction is inter-subject variability and non-specicity.
The former means that T wave parameters are not comparable inter subjectively.
They are useful only when their change is investigated as a function of time and
when ECG signal is stationary. If the same parameter is measured from another
patient it is not guaranteed to measure the same cell level phenomena or, conversely,
the same change in the cardiac state can cause completely dierent change in the
ECGs of the two individuals. The latter means that two dierent cell level changes
can cause similar changes in the surface ECG. In addition, in subjects with advanced
heart disease or conduction defects, T wave is ambiguously dened and sometimes
impossible to quantify automatically, T wave morphology changes as a function
of heart rate [13] and gender [45, 19]. These complicate things further and mean
additional technical and conceptual challenges.
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3.1.2 QT interval
Measurement of the duration of the QT interval has become a standard procedure
in many commercial devices during the past years [37]. Despite its wide spread
application in long term risk assessment, its clinical usability as a risk factor of
imminent VTA episodes in general population is yet to be demonstrated. QT vari-
ability (QTV) is a measure of changes in QT interval morphology and duration
with non-alternans characteristics. QTV is closely related to the T wave alternans
(TWA) and often called complex T wave variation or T wave lability.
Beat-to-beat changes in repolarization are known to increase heterogeneity of repol-
arization throughout myocardium which predispose to initiation and maintenance
of reentry arrhythmias [85]. Both shortening, with shortened cycle lengths, and pro-
longation of QT interval seems to increase the risk of arrhythmia in patients with
[17] and without [37, 85] a structural heart disease. Abrupt changes in HR, fre-
quently observed before VTA episodes, has motivated Zareba et al. [85] to suggest
misadaptation of QT to rapid changes in heart rate to be the most likely reason
for increased number of beats showing substantial QT prolongation in patients with
arrhythmic events when compared to controls. In addition, it has been shown that
QT dynamicity, expressed as QT/RR slopes, is related to haemodynamic status and
bears some prognostic value [37].
Several research groups have studied the dynamics of QT interval prior to the onset
of an arrhythmia. However, major discrepancies exist among the results. Lewicke
et al. [35] measured QT intervals of beats preceding a spontaneous initiation of a
VTA using data stored in wearable cardioverter debrillators (WCDs). Comparison
between the pre-onset and a control period with the same heart rate showed no
statistically signicant change in the QT interval duration. Similar results were
obtained by Shusterman et al. using Holter ECGs [65] and Sachdev et al. [57]
using long-term surface ECG recorded from patients in ICU. By contrast, Diem et
al. [15] used ICD data to demonstrate a signicant prolongation of the QT and
corrected QT (QTc) times before the onset of a VTA episode as compared to a
baseline reference values in patients with structural heart disease and Fei et al. [17]
observed signicant shortening of the QT interval prior to the onset of VTA in
patients without structural heart disease.
The discrepancies between the results may be, for example, due to the absence of
inclusion of heart rate independent factors, like sex, haemodynamic state, drugs,
autonomic nervous system tone, time of the day, age etc. [37, 85]. Another con-
founding factor may be the diculty of dening and measuring T wave in some
cases. Namely, computerised methods work well in the presence of good quality
ECG and monophasic T waves, but unfortunately this is not true for abnormal
electrocardiograms with the T wave not clearly dened morphologically or char-
acterised by irregular morphologies. Furthermore, if the dynamic variation of QT
interval to heart rate is evaluated on beat-by-beat basis, as is the case in many
published reports, the QT/RR relation will probably mix up the two phenomena
of QT adaptation and QT dynamicity, since steady-state cannot be reached after a
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single RR interval [37].
3.2 Variability Parameters
In this subsection parameters that are related to the alterations and variability of
the heart beats are reviewed. These parameters are well studied and understood
in the context of long-term risk of cardiac arrhythmia ratication. However, in the
context of short-term prediction, existing studies have more contradictory results.
3.2.1 Heart Rate Variability and RR Dynamics
As mentioned above (see Ch. 2.1.7), the risk of sudden cardiac death is known
to vary during a day, being highest in the morning and evening and lowest during
the night [22]. This, and other ndings, strongly suggests that autonomic nervous
system (ANS) has a role in SCD and arrhythmia onset. Especially, a variety of
experimental and clinical data supports the hypothesis that increased vagal tone
reduces the risk of malignant VTAs, whereas sympathetic stimulation enhances it
[37]. In addition, an increase in heart rate has been observed preceding the onset of
ventricular tachyarrhythmias (VT) in the majority of patients in whom spontaneous
initiation has been recorded, which suggests elevated sympathetic and/or diminished
parasympathetic activity. [64]. Findings are controversial, however, and there is no
consensus whether dierent branches of ANS have a signicant role in the initiation
of VTAs. Since the ANS is the most signicant modulator of the heart, especially
sinoatrial (SA) node and, consequently, heart rate, the idea in heart rate variability
(HRV) measurement is to quantify short- and long-term variation of the HR. With
some limitations, these oscillations reect changes in the relative balance between
the sympathetic and parasympathetic branches of the ANS, i.e. the sympathovagal
balance [10, 37].
Based on the physiology of the ANS, the activity of the two branches is generally
thought to be seen as oscillations of the HRV at very dierent frequencies. The
high frequency (HF=0.15{0.4 Hz) component is parasympathetically mediated and
reects primarily respiration-mediated HRV. Below HF, low frequencies (LF=0.04{
0.15 Hz) are modulated by both branches of ANS and strongly aected by the
oscillatory rhythm of the baroreceptor system. Furthermore, very low frequencies
(VLF=0.003{0.04 Hz) may represent the inuence of the peripheral vasomotor and
renin-angiotensin systems and, nally, ultra low frequencies (ULF= 1:15 10 5{0.4
Hz) that encompasses all variations in HR with a period of more than 5 min to 24
hours, and reects primarily circadian rhythm. In addition to frequency domain,
time domain, non-linearity based methods and higher order statistics have been
exploited when studying HRV [37, 10].
Regardless of the success of linear parameters in predicting patients susceptible to
SCD in long-term follow-up studies [37], the results are controversial in demonstrat-
ing the causal relationship between abnormalities in HRV and the onset of VTAs
29
[55]. Huikuri et al. [28] found signicant changes in multiple frequency and time
domain HRV parameters occurring in the 1 hour period before the onset of a VTA
distinguishing sustained from non-sustained VT. These ndings were conrmed by
Shusterman et al. [63] using Holter recordings and by Pruvot et al. [52] and Lom-
bardi et al. [36] with data from implantable cardiac debrillators (ICDs). Despite
these promising ndings, subsequent and some contemporary studies have failed
to repeat the results, see e.g. [79, 26, 44, 43, 80, 57]. Both Wessel et al. [80],
Zhuang et al. [86] and Meyerfeldt et al. [43] found no signicant dierence in linear
HRV parameters between pre-VTA and normal control periods but found signicant
changes in non-linear parameters using data from ICDs. In addition, Makikallio et
al. [44] obtained similar results using long-term ECG recordings and Huikuri et
al. [26] found that the ratio of instantaneous to long-term beat-to-beat variability
increased during 1 hour period preceding the onset. These ndings strongly suggest
that various non-linear parameters, including entropy measures [86], symbolic dy-
namics [43], nite growth rates [80], correlation exponent and power-law slope [44],
could be used in short-term VTA prediction. The assessment of HRV by means of
linear parameters, however, fails generally due to non-stationary character of the
ECG signal prior to the onset of a VTA [26].
The eect on HRV parameters is heterogeneous and aected by individual patient
characteristics, which may explain the conicting evidence in the literature [55]. It
is well known that clinical investigations should be controlled for drugs, age, gender,
physical and mental activity, methods recording and analysing, and pre-existing
conditions [10]. This is, however, usually impossible with the small patient popula-
tions used in the studies. For example, it has been suggested that decreased HRV
identies patients at risk for VF or unstable VT, but not patients with inducible
or clinically stable monomorphic VT [37]. Since most of the studies do not dis-
criminate these two groups, this can be a confusing factor. Furthermore, erratic
sinus rhythm increases HRV and may confound its predictive value. Episodes of
erratic sinus rhythm (ESR), assumed to be as a high-degree of non-respiratory sinus
arrhythmia with normal P waves, are seen on Holter recordings in the elderly and
cardiac patients [74, 16]. In addition, frequent PVCs ruin the measurement of HRV.
Multiple acceptance ratios are used ranging from 10 PVCs per hour to up to 15% of
all RR intervals (see [55]) and ectopy removal or replacement is shown to be essential
regardless of the spectral estimation technique [11].
It has been suggested by Sachdev et al. [57] that prediction of imminent ventricular
arrhythmias based on measures of autonomic function is applicable only in patients
with normal baseline values. Furthermore, Anderson et al. [5] found that changes in
HRV precede only VTAs that are initiated by a complex with similar morphology to
subsequent complexes and Meyerfeldt et al. [43] found that fast VTAs (cycle length
< 270 ms) are preceded by decreasing trend in HR and, respectively, slow VTAs
are characterized increased HR. Shusterman et al. [64] have suggested that baseline
levels of HRV may determine HRV changes in response to short-term autonomic
perturbations prior to VTAs. These ndings suggests that alterations of autonomic
nervous system activity is not associated with all VTAs and more attention should be
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paid to the patient group division. Furthermore, it has been suggested that merely
a change in HRV, rather than the magnitude or nature of the change, facilitates the
initiation of VTAs [55].
3.2.2 T Wave Alternans
T wave alternans (TWA) is dened as a beat-to-beat alternation in the magnitude of
successive T waves that repeats every other beat [65] and is thought to manifest the
temporal heterogeneity of repolarization. Furthermore, it has been suggested that
TWA can be a marker of action potential duration (APD) alternation (e.g. caused by
abnormal calcium handling), increased tone of sympathetic nervous system activity
or impaired adaptation of the conduction system to faster heart rates may contribute
to the emergence of alternans in the setting of heart failure [37]. The microvolt level
measure of TWA is widely used as a measure of susceptibility to VTAs and SCD
[37]. Recently, an increase in T wave alternans has been reported to precede an
imminent onset of VTA in several animal models and animal studies of ischemia
induced VF [47]. In addition, TWA has been mechanistically linked to the onset of
VF in a mathematical model [21]. These ndings have led to the conclusion that
TWA might serve as a short-term predictor of these life-threatening events [37] and
motivated to study T wave dynamics prior to the onset of VTA episodes.
Recently, multiple studies have been conducted to discover whether a spontaneous
initiation of VTA and increased TWA have a causal relationship [66]. Shusterman
et al. studied repolarization dynamics before spontaneous initiation of VTA using
human ambulatory ECG recordings [65]. TWA was found to be increasing, peaking
10 minutes before the onset of VTA with a peak value of 23:611:7 V . In addition,
an upsurge in non-TWA repolarization instabilities (i.e. longer-period oscillations)
and heart rate was found to precede an event. Interesting studies by Nearing et al.
[47, 46] demonstrate, by using a canine model of acute ischemia, that an increase
in TWA and other repolarization instabilities precede the imminent onset of VF
episodes. Interestingly, the changes were found to occur predominantly in the early
half of the T wave in both of these studies. The similarities in the ndings of these
two studies suggest that there may be the same electrophysiological mechanism
linking TWA to the initiation of arrhythmias in acute ischemia and chronic structural
heart disease [65]. Maury et al. [41] studied alternans in various T wave morphology
parameters using data stored in ICDs prior to the onset of a VTA episode. In this
study, increased TWA was observed to precede half of the episodes.
So far, the analysis has mainly focused on TWA alone ignoring other types of re-
polarization instability that has been shown to arise before the onset of VTA [66].
It is unclear, whether TWA is the only form of repolarization instability that arises
before the onset of arrhythmia or whether it represents a larger class of instabilities
that coexists minutes to hours before the event [65]. The multiform repolarization
instabilities could also be a result of complex and profound changes in the pattern of
cardiac rhythm that occurs in the studied population during the 1 to 2 hours before
the onset on VTA [65, 62]. Consequently, it is suggested by Shusterman et al. [66]
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that the assessment of TWA needs to be dynamic and personalized to take into
account the time evolution of risk and individual history and at least 120 minutes
of continuous data is needed to draw any reliable conclusions.
3.2.3 Characteristics of the Rhythm Preceding VTAs
Occasional ndings from individual recordings have motivated the search of precurs-
ors of VTA episodes from beat-to-beat analysis of ECG recordings. The episodes
are usually preceded by a complex and changing pattern of abnormal heart beats
including, e.g., single PVCs, segments of bigeminy and trigeminy [34], short PVS
runs, escape beats, short-long-short sequences, early coupling (R on T phenomena)
etc. Resent large-scale studies, however, suggest that frequent premature complexes
or episodes of "warning" arrhythmias do not provide independent prognostic inform-
ation in patients with heart failure and such arrhythmias are present, for example,
in as many uncomplicated myocardial infarctions as in infarctions complicated by
VF [9]. However, VTA episodes or PVCs that alter the hemodynamic stability
are known to be more dangerous [25]. Furthermore, increased frequency of PVCs,
i.e. increased ventricular automaticity or triggered activity, may be a manifestation
of, e.g., enhanced sympathetic and/or decreased parasympathetic tone, acidosis or
hypoxia [58]. Consequently, changes in the predominant rhythm may reect ar-
rhythmogenic changes.
3.3 Conclusions of Review
In general, current research on precursors of VTAs can be characterised by small
sizes of databases that are not publicly available, ndings are not reproduced by in-
dependent investigators and methods are not clearly documented and standardised.
Because of these limitations, even the most promising results must be evaluated
critically.
In essence, every parameter is both failed and succeeded in the prediction of forth-
coming VTA episode. It seems that variation in patient population size, history,
medication, diagnosis etc., methods used and inclusion criteria confound the res-
ults. This is a manifestation of the complexity that is included and not taken into
account. Given that the results show such a high degree of variability for all the
parameters, it appears unlikely that an ECG arrhythmia predictor with high sens-
itivity and specicity would emerge.
All the studies try to identify general changes on group level. However, due to
variability between patients, it is likely that this can not be done by using only
ECG. Moreover, statistically signicant results in clinical studies do not give a clear
insight into the mechanisms of arrhythmias in individual patients [34]. Thus, it may
be possible to identify some changes that have useful prognostic value even though
they fail to correlate with initiation of an event on group level.
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4 Materials and Methods
As concluded in the previous section, it is unlikely that one could predict a forth-
coming VTA episode with good sensitivity and specicity by trending a single ECG
based parameter. However, less has been studied how parameters change with re-
spect to each other and as a function of changing heart rate and if there are any
changes in these relations prior to an event. Based on these poorly studied phenom-
ena, a new idea of arrhythmia prediction is presented.
In this chapter the methods used in this thesis to extract useful features from ECG
signal are presented together with detailed description of our arrhythmia predic-
tion algorithm. In addition, the arrhythmia databases used for development and
validation are characterised.
4.1 ECG as a Measure of Cardiac State
The state of the heart is determined by the states of all the cell constituting it.
Findings in autopsies strongly suggest that the primary cause of arrhythmias arises
as a result of pathological changes aecting the working ventricular myocardium,
making ECG an attractive measure of the cardiac state. Unfortunately, ECG gives
highly non -specic information about these states. The main factor masking the
information about the true cardiac state as measured by surface ECG is ill-posedness
of the inverse problem of ECG [39]. This means that surface ECG has an inherent
limitation as a diagnostic tool: given a distribution of body surface potentials one
can not know the distribution of potential in the heart. In addition, ECG signal
may change independently of changes in the cardiac state, e.g., due to changes in
electrode contact or patient movement. These changes may be inseparable from
true changes. Despite these limitations, ECG is a very useful clinical tool when its
limitation are properly taken into account when analyzing results and developing
new algorithms.
When a change takes place in the cardiac state, it can be observed as a change
in ECG parameters or as a change in relationship between the parameters. For
example, all morphology parameters depend on heart rate and change as a function
of changing RR interval and this heart rate dependency may change when the cardiac
state is altered. Consequently, ventricular arrhythmia is predicted in this thesis by
detecting both types of changes.
4.2 Algorithm for Arrhythmia Prediction
An algorithm was developed to measure various parameters from an ECG signal
to be used in arrhythmia prediction. The algorithm consists of both existing and
tailor-made subroutines (see Fig. 15 for an overview).
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4.2.1 Structure of the Algorithm
- Analyzes the patterns 
of parameters
- Detects changes in 
parameters
- QRS complex detec-
tion and beat to beat 
annotation using 
EK-Pro V 13 algorithm
EK-Pro V13
Preprocessing
Removal of:
- baseline wander
- powerline interference
- high-frequency noise
Feature extraction
Change detection
- Morphology features
- Heart rate (RR/HRV)
- Variation parameters
ECG data
Unfiltered multichannel 
ECG data
Arrhythmia Prediction
Classification of change to 
malignant or benign based 
on prediction rules.
data
- annotations
- fiducial points
Figure 15: The overview of the prediction algorithm.
Measured ECG signal is processed using GE's EK-Pro version 13 algorithm [1]. The
algorithm classies every beat and detects various arrhythmias. The annotation
le given by EK-Pro contains beat classications, ducial points and arrhythmia
onset and oset times. The annotation le is used in the preprocessing and feature
extraction routines of our prediction algorithm.
Preprocessing removes high-frequency and powerline interferences using linear lter-
ing and baseline wandering using polynomial tting. The feature extraction proced-
ure is responsible for extraction of all the parameters from the preprocessed ECG
signal.
Change detection routine analyzes the time series of parameters that are stored in
the feature extraction. The routine makes alerts if it detects changes that predict
imminent arrhythmias. Finally, the alerts are handled in the arrhythmia prediction,
which contains decision rules and threshold values.
4.2.2 Preprocessing
The analysis of a biosignal requires a great deal of signal preprocessing and ECG
makes no exception. Robust preprocessing is an essential step in more advanced
phases of ECG signal processing.
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QRS detection
Robust detection of QRS complexes is essential for any successful analysis of ECG
signal. In our work detection is done using GE's EK-Pro version 13 algorithm [1].
This algorithm is also running in the latest GE monitors used in hospital throughout
the world. Details of QRS detection are not given here.
Removal of baseline wander and high-frequency noise
Preprocessing removes high-frequency noise by using linear FIR-ltering with Cheby-
chew window and cut-o frequency of 45 Hz. FIR-ltering is favoured over IIR to
prevent any morphology distortions due to a nonlinear phase response.
Low-frequency baseline wander is removed by searching the isoelectric level of each
signal in the PQ segment and removing the approximated baseline error, see Fig.
16. The error is estimated using a nonlinear cubic spline approximation (polyno-
mial t) as suggested in [10, 73]. The procedure includes search of the isoelectric
level preceding each QRS complex (see Algorithm A1 in Appendix for details). The
algorithm assumes PQ segment to remain stable throughout the recording. If this
requirement is not met with all recordings, erroneous measurements of other para-
meters will occur since they are measured using the isoelectric point as a reference
point. Since certain conditions, such as atrial arrhythmias and some conduction
abnormalities, can destabilize the PQ segment, all recordings are manually veried
and such cases are excluded from the study.
Vector ECG
In order to compare signals measured using dierent subsets of channels of 12-lead
ECG, they are mapped to the Cartesian coordinate system by estimating the x,y
and z components of the signal. These signals approximate vector-ECG.
In the simplest forward model of ECG, a patient is assumed to be homogenous
spherical conductor with a single dipole in the centre (a heart vector) [39]. In this
model, the measured signals are just projections of the heart vector with correspond-
ing lead vectors (see Fig. 17). The data used in this thesis contains four channels
of ECG (I,II,III and V1/V2). Thus, we have the following projections:
aI  s = sI ; aII  s = sII ; aIII  s = sIII ; and aV  s = sV : (1)
Here, s 2 R 3 is representation of the signal in the Cartesian coordinate system,
ai 2 R 3 is the projection vector of lead i and si 2 R is the signal in lead i. This can
be written as overdetermined linear system
s12 =
2664
sI
sII
sIII
sV
3775 =
2664
aTI
aTII
aTIII
aTV
3775
24sxsy
sz
35 =
2664
0 1 0
0 sin(=6)   cos(=6)
0   sin(=6)   cos(=6)
1 0 0
3775
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35 = As: (2)
The minimum mean square error (MMSE) estimate for s is obtained by using the
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Figure 16: Example of ECG baseline wander removal. Original (red) and corrected
data (blue) are presented as a function of time. Red asterisks are ducial points from
the QRS detector and blue asterisks are found isoelectric positions that are used as
nodes in the polynomial tting.
pseudoinverse of A, denoted as Ay,
s  (ATA) 1ATs12 = Ays12: (3)
The assumption of spherically symmetric conductor is, of course, a rough approxim-
ation and is known to be highly inaccurate [39, 6]. However, the transformation to
the orthogonal space enables representation and comparison of redundant informa-
tion of 12-lead system with varying measurement conguration.
4.2.3 Feature Extraction
After the steps presented above, the data is ready for more advanced feature ex-
traction. The ECG signal is analysed segment by segment. For each segment a
dominant beat morphology is calculated using a template matching procedure (see
Fig. 19). The obtained dominant beat morphology in the segment is used for mor-
phology feature calculation. In addition, beats accepted in the template matching
procedure are used to obtain the variational parameters for the segment. See Fig.
18 for illustration of the feature extraction process.
Template matching and estimation of dominant beat morphology
The method of template matching is used to detect QRS complexes representing
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Figure 17: Transformation of standard ECG leads to vector ECG representation.
beats with ectopic origin and align accepted ones (see Fig. 19). The template
matching is initiated by nding the dominant beat morphology from the beginning
of the signal. The dominant beat is then used as the rst template.
After initialisation, beats are processed sequentially by aligning them with the tem-
plate beat and computing correlation and dierence (error) in ST segments. If both
correlation and ST-error are within predened acceptance threshold values, the beat
is accepted and stored. Using these two inclusion criteria, it is possible to measure
ST-segment parameters robustly from the template. After storing the beat, the
template is updated, which increases the acceptance ratio as the beat morphology
is transiently changing. If the dominant morphology changes suddenly, e.g. when
the direction of depolarization changes, the algorithm estimates the template from
the near history of rejected beats.
The beats accepted in the template matching process are saved and morphology
parameters are extracted from these beats.Extraction of the variation parameters,
e.g. HRV and QTV, requires beat-to-beat analysis of the signal. As a side product
of template matching, a beat history is saved and these beats are used to estimate
variabilities.
4.2.4 Parameters
The parameters chosen to be measures of the state of heart in this thesis have
demonstrated to possess some predictive potential or are related to the mechanisms
of arrhythmias (see literature review in Ch.3). Parameter are classied as morpho-
logy and variation parameter depending on which characteristics they measure and
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ECG signal.
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how they are measured from the signal.
Morphology parameters
Morphology parameters are features measured from a beat representing a dominant
morphology in a segment of ECG signal. To measure both depolarization and re-
polarization processes robustly, all the signal are transformed to vector ECG before
analysing. Using vector representation of the signal one can separate the analysis of
morphology from direction of de- or repolarization and monitor morphology para-
meters continuously.
Parameters describing depolarization are QRS complex duration, maximal vector
magnitude and polar coordinates of QRS complex. The ST segment of the signal is
characterized by two parameters. ST level is mean signal amplitude in this segment
and ST slope is the slope of linear t to the samples of the segment. Repolariza-
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tion descriptors include maximal vector magnitude, position and polar coordinates,
angle between maximal re- and depolarization vectors (QRS-T angle). In addition,
area, symmetry and atness of the vector ECG describing repolarization process are
measured. Symmetry is dened as a sum of dierence between left and right sections
of T wave and atness is dened as a ratio of mean T wave amplitude to maximal
T wave amplitude. To measure duration of one cardiac cycle QT time is included
to the parameters. See Fig. 20 for illustration of the morphology parameters and
the calculation process. To enable patient-by-patient comparison, parameters are
normalised to average maximal QRS deviation over the entire recording.
Variation parameters
Variational parameters are measured from a segment of ECG signal by aligning
beats belonging to the segment and measuring their variation, see Fig. 21.
Variation in T wave is measured both in voltage and time. T peak amplitude
variation is the variance of T wave amplitude measured at its peak and T peak
time variation is variance of T wave peaks position in time. In addition maximal
variation in the ST-segment, i.e. ST lability, is measured.
Rhythm parameters
Changes in the rhythm preceding VTA episodes are frequently observed. To measure
these changes the rhythm is analysed segment by segment. The parameters selected
are average heart rate between consecutive sinus beats, heart rate variability (HRV)
and ratio of PVC to normal beats, i.e. PVC ratio.
Control parameters
A few of the above-mentioned parameters are used as control parameters. The pur-
pose of these is to detect changes that aect repolarization but are not related to real
changes in the cardiac state or myocardial repolarization. Stability of depolarization
is measured using QRS amplitude, QRS-T angle and position of QRS maxima. In
addition, abrupt change in the position of T wave maxima can cause unwanted dis-
continuity in the measurement of morphology parameters. Thus, the position of T
wave maxima is used as a control parameter. To prevent noisy segments from caus-
ing false prediction alarms, rejection ratio is used as a control parameter. Rejection
ratio is the ratio of accepted to rejected beats in a segments.
4.2.5 Fast Change Detection
There are various possibilities for sources of change in ECG. A change can be very
fast, occurring between adjacent beats, or it can take up to hours to occur. Further-
more, it can be seen as altered relationship between the parameters or directly in
parameter trends. In order to detect both fast and transient changes two dierent
strategies are used.
A segment i of the ECG signal, beginning at ti, is used for the extraction of a
feature vector xi 2 R N , where N is the number of features extracted. By writing
these vectors as columns of a matrix X 2 R NM , one obtains (with M segments)
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Figure 21: Measurement of T wave variation parameters.
X =

x1 x2 : : : xM

: (4)
In order to detect fast changes in parameter values two dierent measures are used.
Mahalanobis distance (MD) is a measure of distance between adjacent segments of
parameters, i.e. xi and xi 1. Unlike regular Euclidean norm, however, Mahalanobis
distance is scale invariant and takes into account the correlation between parameters.
Rationale for utilization of Mahalanobis distance in change detection lies in the
fact that measured parameters correlate with HR and with each other. Correlation
between parameters can be presented as a correlation matrix, which can be estim-
ated from the data. This way the Mahalanobis distance is insensitive to a normal
oscillation and change predictable by earlier data, but larger distance is measured if
the parameters do not "t in the picture" of previously measured covariance matrix.
Mahalanobis distance, d(xi;xi 1) 2 R, between adjacent segments is
d(xi;xi 1) =
p
(xi   xi 1)TC 1(xi   xi 1); (5)
where C is the estimated covariance matrix.
For a limited range of HR all parameters x can be approximated by using some
mapping x = f(HR) : R ! R. The same applies to the dependencies between all
parameters. As an example, HR is known to modulate QT time. Thus, QT time
alone is not relevant measure but function QT(HR) is. Moreover, if value of QT
changes a way not predictable by the function QT(HR) the change can be regarded
as a change in underlying cardiac state, not just manifestation of changing heart
rate (see Fig. 22 for a schematic illustration). Since the true mapping between
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a parameter and heart rate is not known in general, we use rst and second order
polynomials to approximate this relationship locally. Resulting polynomials are then
used to calculate tting error ratio, which is the ratio between residual error of data
used for tting and error of future samples (not used in the tting) as predicted by
the model.
Let us say, we have a parameter vector x measured over time and corresponding
RR interval values stored in vector y. In order to calculate the tting error ratio, a
predened number of segments is used to t the rst and second order polynomial
to data. In general, tting can be done by solving the following overdetermined
system for p
y = Ap; (6)
where p contains polynomial coecients and A is linear mapping between the coef-
cients and the measurements y. The LMSE estimate for p is calculated using the
Moore-Penrose pseudoinverse:
~p = Ayy: (7)
Next, the goodness of t is evaluated by calculating model predicted values for the
data used in tting and for unseen future data xfut. For tted data ~y = A~p and
for the future data ~yfut = Afut~p. Finally, tting error ratio (FER) is calculated as
follows
FER =
jjyfut   ~yfutjj2
jjy   ~yjj2 : (8)
The tting error ratio is calculated for various parameter pairs and, nally, the value
used for ventricular tachyarrhythmia (VTA) prediction is obtained as a sum over
the parameter pair FERs.
The idea of the two measures of fast change described above is illustrated in Fig.
22. The green samples are measured parameter and heart rate values that are used
to estimate both covariance and linear estimate of the heart rate dependency of the
parameter (green dashed line). Red solid line is the true relationship between the
parameter and heart rate. Furthermore, blue and red samples represent two possible
changes occurring after the green samples. As can be seen in the image, Euclidean
distance is not very good measure of change since distance d2 is signicantly greater
than d1 in spite of blue samples are just normal values for the parameter at slower
heart rates. The equidistant lines of the Mahalanobis distance measure are illus-
trated as ellipsoids around the sample mean. Thus, Mahalanobis distance gives
approximately the same distance for the two possible sample sets. For the tting
error ratio, however, the red samples are notably further from the estimated linear
map than blue ones. Consequently, a signicant change is detected when progressing
from green samples to red ones but not when blue samples are detected.
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Figure 22: Green samples are used to calculate the covariance matrix and linear es-
timate of dependency between two parameters. Red samples are closer to the samples
mean than blue ones in Euclidian distance but the distance is approximately the same
when Mahalanobis distance is used. The tting error of the blue samples to the lin-
ear estimate is substantially smaler than the tting error of red samples, thus tting
error ratio is potentially a good measure of change of the state of the heart.
4.2.6 Transient Change Detection
Slow changes can not be detected easily using Mahalanobis distance or the tting er-
ror ratio (FER), thus, in order to detect these slow changes, an alternative strategy
is used. Based on ndings in the group level trends in the development data, a
subset of parameters is selected and a linear combination of them is calculated to
obtain an optimal linear combination (OLC). It may be possible that some linear
combination of the measured parameters is better predictor than any parameter
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alone. To assess applicability of such a combination, coecients of the linear pro-
jection where optimized to maximize the increase of the linear combination in the
training arrhythmia data while minimizing the change among the control cases, see
Fig. 23).
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Figure 23: Time evolution of optimal linear combination (OLC) over arrhythmia
and control development data.
Linear combination signal is calculated for selected parameters with coecients
a 2 R N (with N parameters) as follows
z =

z(1) z(2) : : : z(T )

= aT

x(1) x(2) : : : x(T )

= aTX; (9)
where z(t) is the linear combination at t and x(t) 2 R N is the parameter vector
measured at time t.
Mean linear combination signal over a group of M patients is calculated simply by
averaging
z =
1
M
(aTX1 + a
TX2 + : : : a
TXM): (10)
Next, we optimize a so that linear t to z has maximal slope. The problem is solved
by nding the minimizer of the following problem (see Fig. 23 for illustration)
argmin
a

0  1Ay(aTX)  (jjajj2  N)2: (11)
Here the rst two-element row matrix is just used to select the second term, which
corresponds to tted slope. The last term just constrains norm of the solution to N .
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In order to nd the minimum, we use Matlab optimization routine fminsearch, which
nds the minimum of an unconstrained multivariable function using a derivative-free
method. The minimizer is
a =
266664
1:3173
0:7524
1:0142
1:0176
0:7965
377775 ; (12)
where the coecients are for T wave amplitude, asymmetry, area, ST-level and ST
slope, respectively.
4.2.7 Arrhythmia Prediction
All the methods presented above aim to one goal, which is prediction of a forthcom-
ing VTA episode. A set of features are extracted from the ECG signal representing
current cardiac state. The arrhythmia prediction routine uses this multi-dimensional
parameter vector stored at every segment. The idea is to detect certain changes that
are manifestations of imminent VTA.
The arrhythmia prediction routine goes through the parameters (Fig. 24) and com-
pares Mahalanobis distance (MD) (Eq. 5), tting error ratio (FER) (Eq. 8) and op-
timal linear combination (OLC) (Eq. 9) to respective threshold values. If threshold
in d or D is exceeded, control signals are used to ensure that the detection is not
caused by an abrupt change in depolarization, classied as secondary repolarization
change, T wave measurement position or lead-o resulting to discontinuity in para-
meter values. If triggered change is not found to be caused by an artifact, or the
value selective sum z exceed its threshold value alarm of increased risk of VTA is
given.
The threshold values are optimized to give minimally false positives in the training
database used in this study. See Section 5.3 for details and illustration of threshold
selection.
4.3 Arrhythmia Database
In order to investigate parameter changes hours prior to an arrhythmia, a large
long-term ECG database is needed. The reported incidence of IHCA is low, 0.175
events/bed annually including all hospital areas [60, 68], which makes collecting very
time consuming and expensive. Fortunately, however, access to a relatively large
high-quality database was available for this study. The database used is a subset of
the data used in a study by Sachdev et al. [57].
The database was recorded at the CCU of Johns Hopkins University Hospital and
Good Samaritan Hospital in Baltimore. Patients with a minimum of 8 hours of ECG
data before an event constituted the study group. Patients with atrial arrhythmias,
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Figure 24: Overview of the arrhythmia prediction. MD = Mahalanobis distance,
OLC = optimal linear combination and FER = tting error ratio. If the threshold
is exceeded in MD, FER or their combination, validity of the prediction is guaranteed
by using control signals.
paced rhythm, frequent PVCs, low signal quality or a conduction block were ex-
cluded. Description of the included 60 patient cases is presented in Table 1 and B1
in Appendix B. For further details see the original article by Sachdev et al. [57].
The database was divided into three groups according to an event seen at the end
of the recording. "Sustained VT/VF" group consist of patients with ventricular
tachyarrhythmia lasting 30 seconds or more, patients in "non-sustained VT/VF"
group have an episode with duration between 5 to 30 seconds, and patients in "no
event" group are used as controls.
Total of 14 sustained, 9 non-sustained and 37 control patient cases were used in this
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study. All cases were used to study the performance of Mahalanbis distance (MD)
and tting error ratio (FER) measures of changes in prediction of VTA episodes.
In addition, the data was divided randomly into development and validation data
in order to study the performance of optimal linear combination (OLC). The devel-
opment data consist of 7 sustained, 4 non-sustained and 15 control recordings and
validation data consist of 7 sustained, 5 non-sustained and 22 control cases.
Arrhythmia Sustained Nonsust No Event Total:
Diagnosis
CAD + AMI 2/1 3/3 5/5 10/9
CAD + AP 0/0 0/0 3/3 3/3
Ischemic DCM 2/4 0/1 4/2 6/7
Non-Isch. DCM 0/1 0/1 1/2 1/2
Prim. Electrophys. Ev. 0/0 1/0 1/0 2/0
Unknown 3/1 0/0 1/0 4/1
Total: 7/7 4/5 15/22
Demographic info
Males 43/43 % 80/100 % 53/64 %
White 57/57 % 50/60 % 60/64 %
African American 29/29 % 50/40 % 27/27 %
Other 14/14 % 0/0 % 13/9 %
Age 67 64 61
Medication
Beta-blocker 14/14 % 50/40 % 47/64 %
Antiarrhythmics 29/43 % 75/60 % 27/41 %
Table 1: Demographic description of the data in development/validation databases.
4.4 Algorithm Development and Validation
To demonstrate the applicability of suggested methods for VTA prediction, some
example cases are shown. These examples, however, illustrate the methods for in-
dividual patients only and group level conclusions can not be made. Predictive
performance of all used methods, i.e. Mahalanobis distance (MD) and tting error
ratio (FER) is evaluated for both sustained VTA and non sustained VTA cases using
all the data to tune the respective threshold parameters. Optimal linear combina-
tion (OLC) is rst optimized in the training data and validated using the validation
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data. The performance assessment of each method is calculated by determining the
specicity and sensitivity in the training group with varying threshold values. Fur-
thermore, the threshold value for the control signals is optimized to minimize false
alarms among the control patients of the training data. Finally, the performance of
the algorithm using alarm rules and combination of the individual change detectors
is assessed. This is done simply by calculating the number of true/false positives
and negatives.
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5 Results
In order to observe group level trends, ECG morphology and variation parameters
are plotted as a function of time before a VTA episode and the trends are compared
to arrhythmia free controls. To demonstrate feasibility of our methods, three patient
examples are shown. The examples illustrate our change detection strategy and
usefulness of the control parameters in false positive rejection at patient level. The
goodness of the change detection methods is evaluated by plotting sensitivity and
specicity separately for all change detectors as a function of time. In addition,
performance of the arrhythmia prediction algorithm is assessed in sustained and
non sustained groups.
5.1 Parameter Trends in Arrhythmia Groups
Mean RR interval is approximately 100 ms faster in sustained group than in non-
sustained and control groups (see Fig. 25). Heart rate does not change signicantly
in any of the groups. Width of the QRS complex, representing depolarization time,
is longest in the sustained group suggesting slower conduction speed in this group.
This dierence is emphasized when higher HR, which increases conduction in normal
heart, in the arrhythmia group is taken into account. Dierences in the mean ST-
level values are relatively small among the groups. However, variation of ST-levels
is largest in the sustained group.
The morphology parameters are measured from the magnitude of transformed vector
ECG signal and they are plotted in Fig. 25. The mean amplitude and area of T
wave demonstrate signicant increase in the sustained group compared to others
initiating up to 2 hours prior to an event. Flatness of T wave magnitude remains
unchanged throughout the measurement in the control group, increases slightly in
the sustained group and as an abrupt drop in the non-sustained group. Asymmetry
of T wave magnitude increases in the sustained group around 2 hours and in non-
sustained group around 1 hour prior to an episode and remains unaltered in the
control group.
Observable trends cannot be seen either in T wave amplitude variation or time vari-
ation values, Fig. 26. However, amplitude variation peaks just before an arrhythmic
event in both arrhythmia groups. Similar ndings can be seen in ST lability. Both
QT time and Fridericia corrected QT time (QTcF) fail to demonstrate any notice-
able trends. Ratio of PVC beats is only slightly increased in the non-sustained group
and increases just before an event in both arrhythmia groups.
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Figure 25: Trends and variation of RR interval and ECG morphology parameters in
dierent arrhythmia groups before VTA episode.
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Figure 26: Trends and variation of variability parameters of repolarization, QT time
and PVC ratio in dierent arrhythmia groups before VTA episode.
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5.2 Characterizing Changes at Patient Level
The group averaged plots presented above do not tell very well what happens to
individual patients before ventricular tachyarrhythmia (VTA) episodes. To charac-
terize typical changes, some example cases are presented here in Fig. 27, 28 and
29.
Patients JH191 had ventricular brillation at the end of the recording. Two typical
relatively fast changes can be seen in Fig. 27. The latter occurs just before 400
minutes has passed from the beginning. Mahalanobis distance is used to detect this
step like change and changes in the control signals are within the threshold values.
Thus prediction of coming arrhythmia is given about one hour before the episode.
Patient JH120 had a VTA episode at the end of the recording. About 2 hours
prior to the onset of the event, the mapping between RR interval and T wave
area changes. Fitting error ratio is used to detect this change and prediction of
approaching arrhythmia is given up to 2 hours before the event.
To illustrate the importance of control signals, thirds example is given in Fig. 29.
Patient JH128 belongs to the control group and does not have any arrhythmia
during the monitoring. 350 minutes after initiation of the monitoring a spike in the
Mahalanobis distance is detected. This would cause a false alarm if control signals
were not taken into account. One can see that the ratio of rejected to accepted
complexes spikes simultaneously with the Mahalanobis and the position of T wave
maximum changes abruptly, which causes rejection of the prediction.
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Figure 27: An example of change in patient JH191 before an arrhythmia detected
by sliding window Mahalanobis distance (see Eq. 5). No major discontinuity can be
observed in control signal and prediction is not rejected.
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Figure 28: An example of change in patient JH120 before an arrhythmia detected by
tting error ration (FER) (see Eq. 8).
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signal can be used to identify false detection.
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5.3 Predictive Performance of the Change Detectors
The performance of the measures of change were evaluated using all the data for
Mahalanobis distance (MD) and tting error ratio (FER) and threshold values for
them were tuned to minimize false negatives in this patient population (see Fig. 30
and 31). In addition, development data was used to nd optimal linear combination
of parameters and validation data was used to assess the usefulness of optimal linear
combination (OLC) measure in VTA episode prediction.
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Figure 30: Sensitivity and specicity as a function of a threshold value for Mahalan-
obis distance (MD) and optimized linear combination (OLC). Threshold values are
drawn as dashed vertical lines.
According to our results, Mahalanobis distance seems to be the best predictor of
imminent VTA episodes while maintaining acceptable specicity. In our data it can
predict approximately 50 % of the sustained cases with 93 % specicity whereas op-
timal linear combination and tting error ratios achieve sensitivity of approximately
20 % each without false positive predictions. OLC was able to predict 44 % of the
sustained cases in the development data but only 15 % in validation data.
For non sustained cases all the predictors seem to give disappointingly low sensitivity.
MD is able to predict only 10 % of the VTA in this group. Both FER-based triggers
fail to predict any arrhythmia while maintaining acceptable sensitivity.
Combination of MD and rst order FER requires both measures to be above pre-
dened threshold values. Specicity and sensitivity of this rule as a function of
threshold value is illustrated for both measures separately in Fig. 33. Threshold
values are dened to give around 30 % sensitivity and 95 % specicity.
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Figure 31: Sensitivity and specicity as a function of a threshold value for 1st
and 2nd order polynomial local t based detectors, i.e. tting error ratio (FER).
Threshold values are denoted as dashed vertical lines.
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Figure 32: Sensitivity and specicity as a function of a threshold value for optimal
linear combination (OLC) in training and validation data.
5.4 Predictive Performance
The performance of the arrhythmia prediction algorithm is evaluated using the data-
base of 60 patients (14 sustained, 9 non sustained and 37 controls). Only three of
the 37 arrhythmia free signals were classied as arrhythmia resulting to 3 false pos-
itive and 34 true negatives. Thus, specicity of the algorithm is around 0:93. Seven
cases in the sustained arrhythmia group of 14 cases were classied correctly giving 9
false negatives and, consequently, sensitivity of 0:50. Positive and negative predict-
ive values are 0:70 and 0:85, respectively, see Tab. 2. In non sustained arrhythmia
group the algorithm detected only one cases out of 9 true events. This suggests that
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Figure 33: Sensitivity and specicity as a function of a threshold value for combin-
ation rule of Mahalanobis distance (MD) and tting error ratio (FER). Left: FER
threshold value is xed to 1.25 and on right MD threshold value is xed to 25.
sensitivity of the algorithm in the non sustained group is approximately 11 % and
specicity is 93 %, see Tab. 3. The mean time from the alarm to the initiation of
an episode is 275 minutes (see Fig. 34).
50 100 150 200 250 300 350 400 450
Mean Init. of VTA
Figure 34: Alarm times.
These measures alone are inadequate in assessing the performance of the algorithm.
The usefulness of the algorithm can be evaluated by considering sensitivity and
specicity in relation to the true incidence of episodes. As mentioned earlier the
incidence of VTA episodes in CCU is around 1-5 % [29]. Let's assume, for example,
an incidence rate of 1 %. If average time in CCU was 48 hours and there were 5 beds
in the unit, 9 patients out of 900 would experience an episode of VTA annually. On
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average, VTA would be predicted in 4.5 cases. Based on the results, our algorithm
gives one false alarm during 176 hours of monitoring. Thus, one monitor would give
49 false alarms annually, about one per week.
Patient
Result Arrhythmia Control
Detection 7 3 0.70 PPV
No detection 7 41 0.85 NPV
0.50 0.93
Sensitivity Specicity
Table 2: Predictive performance of the algorithm for sustained VTA patients.
Patient
Result Arrhythmia Control
Detection 1 3 0.25 PPV
No detection 8 41 0.84 NPV
0.11 0.93
Sensitivity Specicity
Table 3: Predictive performance of the algorithm for non sustained VTA patients.
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6 Conclusions
6.1 Conclusions of the Results
6.1.1 Group Trends
The most common nding in the literature prior to ventricular tachyarrhythmias is
an increase of heart rate (HR). The change in HR may cause the change of other
parameters. However, HR does not change signicantly in either of the arrhythmia
groups and can not explain the observed trends in this study. Furthermore, changes
in the ST segment of ECG are known to be sensitive of ischemic conditions in the
myocardium. All three groups contain approximately same proportion of ischemia
related conditions. Thus, it is unlikely that the dierences can be explained only by
properties of the study groups. However, variance in all parameters is high, which is
a result of high inter-subject variability and reduces statistical power of the results.
Furthermore, due to small study population, dierences in the group means can not
be considered statistically signicant and the impact of a single outlier in the group
can be signicant.
Based on our results, the most relevant morphology parameters distinguishing the
arrhythmia cases from the controls are T wave magnitude, area, asymmetry and
ST-slope. Among variational parameters, both T peak amplitude variation and
maximal variation in ST segment, i.e. ST lability, demonstrate slight increase in
both arrhythmia groups compared to the control group. These changes could be a
manifestation of increased spatio-temporal repolarization.
It was concluded in our review in chapter 3 that it is unlikely that VTA prediction
succeeds when one uses parameter trends as a sole input to a prediction algorithm.
Indeed, our results conrm this conclusion.
6.1.2 Prediction Performance
There were three false positive in our study and, consequently, our estimate of the
specicity of the algorithm, 0.93, is surprisingly good. The size of the control group
is only 37 cases (296 hours), which decreases reliability of our estimate. In order to
get more reliable estimate of specicity, a much larger database of control recordings
would be needed.
In the study, 7 out of 14 patients in the sustained group triggered alarm whereas
only one out of 5 patients was classied as arrhythmia in the non sustained group.
This gives relatively good estimate of sensitivity for sustained VTA group and poor
for non-sustained group, 50 % and 0.11 %, respectively. Thus, it seems that with our
algorithm, sustained arrhythmias are predictable whereas non sustained arrhythmias
are not. This nding supports the idea that short VT/VF episodes may be just
random whereas for an arrhythmia to persist detectable changes in the heart must
take place.
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The mean time from alarm to initiation of an episode was around 275 minutes. Even
the shortest time, 10 minutes, is reasonably long time if one planned to use some
preventive strategies or just increase the alertness of the sta.
Mahalanobis distance (MD) and tting error ratio (FER) measures are based purely
on change detection. The database was too small to facilitate the usage of any more
intelligent classication methods to classify the change. It can be assumed, however,
that common characteristics could be found from changes and they cold be used to
decrease false alarms.
Optimal linear combination demonstrated promising trend in training data and was
able to detect 30 % of the cases. In validation data, however, only one case was
detected both in sustained and non sustained data. This suggests that our method
was unable to learn anything general from the training set that could be used for
prediction in general.
6.2 Issues with the Data
Diculties in obtaining noise-free electrocardiographic data immediately preceding
a lethal arrhythmia is a major disadvantage in development of predictive algorithms.
Analysis of implantable cardioverter debrillator (ICD) data is limited by the storage
capacity of the devices, and the advantages of Holter data are oset by the low
probability of capturing such events in an ambulatory population. In addition, this
study demonstrates that the duration of the recordings should be at least 4 hours
in order to be usable in predictive algorithm development.
Due to above-mentioned problems the size of database used is usually very limited
and there is a lack of high quality ECG databases with lethal arrhythmias. In
addition, heterogeneity of the population (medication, diseases) and measurement
setup (channels used) is a major problem. To conclude, current databases are often
noisy and as predictive algorithms require high signal to noise ratio, this provides
extra challenges for algorithm development.
6.3 On Building an Automatic Arrhythmia Prediction Al-
gorithm
The ultimate goal of this thesis was to build an automatic algorithm capable of
estimating the risk of lethal arrhythmias. Here are some suggestions what to take
into account when implementing such an algorithm. Firstly, no stationarity as-
sumptions can be made due to the unstationary nature of ECG preceding VTA
episodes. This means that most of the traditional and trendy measures will fail to
measure anything useful from the ECG that is not even approximately stationary.
Secondly, one needs to consider intra-subject variability more carefully and it may
be necessary to distinguish patients with dierent medication, illness, current state
and history. To conclude, the risk of VTA/SCD evolves over time with changes in
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electrophysiologic substrate, environmental and physiologic triggers, and the impact
of other physiologic (e.g. circadian) rhythmicity [66]. Thus, the parameters per se
are highly non-specic and should be investigated with relation to other parameters,
patient state and history.
Based on the ndings from this study an abnormal change in the heart seems to
trigger arrhythmias. Thus, it may be that change in cardiac state itself, not its dir-
ection, is essential in the initiation. Furthermore, it seems that both fast and slow
changes are relevant but may require dierent methods for detection. The inconsist-
encies most likely arise from the dierences in the underlying physiologic mechanisms
driving the instabilities in dierent settings, leading to a common end point from a
multitude of subcellular, intracellular, and multicellular processes. In real-life set-
ting, electrophysiologic data are usually collected at the time when at least some
of the covariates exhibit simultaneous changes. Thus, algorithms are needed to dif-
ferentiate the respective impacts and weights of each participating covariate. The
practical implementation of the algorithm requires continuous tracking of individual
repolarization dynamics, along with other electrophysiologic parameters, including
changes in heart rate, QRS duration (i.e. conduction), circadian variability, physical
activity, and physiological status. Improvements can also be achieved by tracking
the changes against individual baseline and using "personalized" pattern recognition
analysis. [66]
6.4 Potential Benets in Clinical Settings
An algorithm that predicts lethal ventricular arrhythmias will reduces delay of re-
suscitation by increasing alertness of the sta and enabling preventive means. Ar-
rhythmias that are debrillable, decreased delay before initiation of CPR is known to
increase likelihood of survival and reduce disabling neurological damage. It is likely
that some preventable episodes could be avoided if predictive algorithm was used for
hight risk patients, e.g. in CCU. Furthermore, continuous monitoring of vital signals
using simple, cost-eective and wireless monitoring in the general ward areas would
enable observation of the slow deterioration, would support decision making, reduce
the work load of nurses and other healthcare professionals and increases alertness.
6.5 Future Development and Suggestions
It is obvious that to conrm the ndings presented in this thesis, one would need
to repeat the analysis using much larger amount of data with separate training and
learning data. The original idea in this thesis was to learn patterns of features
preceding episodes and to test if these patterns are present in the validation data.
Because of scarcity of data this remains to be done, however. Furthermore, it
would be interesting to test which parameters work for dierent patient classes, like
morphology for ischemia and alternans for myopathy.
An interesting topic in future research would be exploitation of multi-parameter
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monitoring already frequent in intensive and coronal care units. For example, mon-
itoring electrical and mechanical properties simultaneously, e.g. ECG and arterial
blood pressure, would enable evaluation of any changes in the electromechanical
coupling of the myocardial cells, which is assumed to cause arrhythmias [56].
Current trend in monitoring is toward continuous around a clock monitoring and
telemetry, wireless, low-power consuming invasive sensors. This opens new possib-
ilities for predictive algorithms, too. Ubiquitous monitoring could mean numerous
people would benet from arrhythmia prediction algorithms. However, even though
we know which ECG or other cardiovascular changes precede ventricular arrhythmias
and SCD, we have no idea who to monitor. This results from the fact that the ma-
jority of sudden deaths occur out-of-hospital in apparently healthy individuals who
show little clinical evidence of latent heart disease during their life [58]. This ques-
tion remains to be unanswered.
In order to make research in the eld more ecient it is important to identify the
patient groups that would benet the most from prevention and for which it is pos-
sible to prevent the onset in the rst place. Then, target the algorithm development
for these patients.
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Appendix A: Algorithms
Isoelectric point search and removal of baseline wandering are the most essential
parts in the preprocessing of an ECG signal. Moreover, the performance of the
baseline removal algorithm is critically dependent on the accuracy of the isoelectric
point determination. In this appendix, the algorithms responsible of these crucial
preprocessing steps are described and derived.
The isoelectric point search algorithm (see Alg. A1) uses the ducial points (loc-
ations of QRS complexes) calculated using the GE EK-Pro software [1]. Since the
QRS complex detector nds the position of each complex around maximal signals
amplitude, the found QRS complex positions are good starting points in isoelectric
position search. Our algorithm goes through one channel of ECG at a time (input
parameter x) locating the isoelectric position preceding each ducial point (input
parameter fp). The algorithm has the following two step search strategy: try to nd
position where the sign of derivative of the signal changes in interval to search for
Q peak (determined by the parameter QS). The second step starts at Q wave or, if
not found, at QS samples before the ducial point. In this step, the algorithm goes
back PQS samples calculating deviation from a atness interval mean. Minimal
deviation from the interval mean means maximally at signal and central point of
it is stored and used as an estimate for the isoelectric position.
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Figure A1: Baseline wandering is removed from the ECG signal using cubic spline
polynomial tting.
Removal of the baseline wander of the signal can be considered as a problem of
nding the wandering signal from the raw ECG data. Since the isoelectric points
can be assumed to have zero amplitude, the baseline signal must pass these points.
The found ith isoelectric positions is denoted as ti and corresponding baseline wander
value at that position is denoted by using the baseline wander signal f(ti) (see Fig.
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Algorithm A1 Search of isoelectric point
1: procedure [I,z] = FindIsoelecticPoint(x,fp)
2: Constants:
3: fs: Sampling frequency
4: T = 1=fs: Time step
5: TQ: Interval to search for Q peak
6: QS = TQ=T : Samples to search for Q peak
7: TPQ: Interval to search for PQ sement
8: PQS = TPQ=T : Samples to search for PQ
9: Tf : Flatness interval
10: L = Tf=T : Samples for atness interval
11: Input:
12: x: ECG data
13: fp: Fiducial point
14: Output:
15: z: Estimated isoelectric level
16: I: Position of the isoelectric level
17: Code:
18: k = fp=T ;
19: sp =sign(x(k   2)  x(k));
20: k = k   2;
21: s =sign(x(k   1)  x(k));
22: while (s 6= 0)&(s = sp)&(fp=T   k < QS) do
23: sp = s;
24: k = k   1;
25: s =sign(x(k   1)  x(k));
26: end while
27: k = k   2;
28: z = 1
L
PL=2
l= L=2 x(k + l);
29: I = T ;
30: minabsdev =
PL=2
l= L=2 jx(k + l)  zj;
31: for m = k   1 : k   PQS + 2 do
32: mean = 1
L
PL=2
l= L=2 x(m+ l);
33: absdev =
PL=2
l= L=2 jx(m+ l) meanj;
34: if absdev < minabsdev then
35: z = mean;
36: I = mT ;
37: minabsved = absdev;
38: end if
39: end for
40: end procedure
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A1. The next step is to use f(ti), f(ti+1) and f(ti+2) to estimate values of f(t) in
the interval t 2 [ti ti+1]. The estimation is done by tting a polynomial to pass
the isoelectric points. Arbitrary shaped baseline wander can be expressed around ti
by using the Taylor approximation. When three derivatives is included we get the
following formula
f(ti + t) = f(t)  f(ti) + f 0(ti)(t  ti) + f
00(ti)
2
(t  ti)2 + f
000(ti)
6
(t  ti)3; (A1)
Where f(ti) = x(ti) is just the ECG signal value at the isoelectric point. The
estimate for the rst derivative is calculated as a linear slope between adjacent
points
f 0(ti) =
x(ti+1)  x(ti)
ti+1   ti : (A2)
We still need the to know the second and third derivatives before we can compute
Eq. A1. In order to get these values we need to consider the following Taylor
approximations when t = ti+1. Thus, we get
f(ti+1)  f(ti) + f 0(ti)(ti+1   ti) + f
00(ti)
2
(ti+1   ti)2 + f
000(ti)
6
(ti+1   ti)3; (A3)
and
f 0(ti+1)  f 0(ti) + f 00(ti)(ti+1   ti) + f
000(ti)
2
(ti+1   ti)2: (A4)
Again, f(ti+1) = x(ti+1) and the rst derivative is
f 0(ti+1) =
x(ti+2)  x(ti+1)
ti+2   ti+1 : (A5)
Now, one can solve f 00(ti) and f 000(ti) from Eq. A3 and A4. The formulae are
f 00(ti) =
6(f(ti+1)  f(ti))
t2i1
  2(2f
0(ti) + (f(ti+2)  f(ti))=(ti2))
ti1
(A6)
and
f 000(ti) =
12(f(ti+1)  f(ti))
t3i1
  6(f
0(ti) + (f(ti+2)  f(ti))=(ti2))
t2i1
; (A7)
where tij = ti+j   ti. Now values for f(t) can be calculated and the procedure can
be applied for the next interval.
75
Appendix B: Database
This appendix contains detailed information of the database used in this study. See
Tab. B1 to see a complete list of patients constituting the study groups, B2 to
decode the abbreviated words in the list and the original study by Sahdev et.al [57]
where the database is described.
Patients who were admitted to the cardiac intensive care unit (CCU) of either the
Johns Hopkins Hospital or Good Samaritan Hospital in Baltimore were candidates
for the study. Patients in coronary care unit (CCU) who experienced an event of
sustained (30 seconds) monomorphic ventricular tachycardia (MVT), polymorphic
ventricular tachycardia (PVT), or ventricular brillation (VF) were identied. Pa-
tients with a minimum of 8 hours of ECG data before the event constituted the study
group. In addition, a group of patients who did not experience any arrhythmic event
while in the CCU was identied at random to serve as a control population. For
controls, a random point in time was taken as the "event": and 8 hours of ECG lead-
ing up to this time point was used for analysis. Specic demographic information
including presenting diagnosis, administration of -blockers or other antiarrhythmic
drugs during the monitored period, and other related conditions were obtained by
chart review.
Electrocardiographic tracings were downloaded from the specialized intensive care
unit MARS telemetry system (GE Medical Systems, Milwaukee, WI) that is capable
of retaining up to 28 hours of multi-lead ECG tracings, ltered between 0.3 and
50 Hz and sampled at 120 Hz, and transferred to a computer for analysis. Each
tracing was considered by event type { MVT, PVT, VF, or control. Noisy ECG
recordings due to motion artifact or electrical noise were excluded from analysis.
Patients with intermittent bundle-branch block, atrial brillation, or excessive back-
ground noise (N10% of record) were excluded because of diculty in analyzing their
data. Patients with more than one major event during the 12-hour period were also
excluded to avoid ambiguity in the time of end point.
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Pat gend/race age event disease B-blocker antiarrhy. valid group
JH 50 w/m 57 3 1a 0 0 0 1
JH 80 b/f 49 2m 5 0 0 0 1
JH 120 b/f 73 2m 2a 0 0 1 1
JH 128 w/f 87 2m 1a 0 1 1 1
JH 167 w/m 66 2p 5 0 1 0 1
JH 191 o/f 72 2m ? 0 0 0 1
JH 69 w/m 48 2m 2a 0 0 0 1
JH 84 w/f 76 2m 1a 0 1 0 1
GS 5 w/f 74 3 2a 0 0 1 1
gs 24 b/f 78 - - 0 0 1 1
JH 78 b/f 67 - 2a 1 0 0 1
JH 14 a/f 70 - 2a 0 1 1 1
jh 141 w/m 40 - 2b 0 0 1 1
jh 184 w/m 53 - 2a 1 1 1 1
JH 29 b/m 65 1m 1a 1 1 0 2
JH 42 w/m 60 1m 1a 0 0 0 2
JH 66 w/m 80 1m 1a 0 1 1 2
JH 77 w/m 64 1p 1a 0 1 0 2
JH 153 w/m 69 1m 1a 1 0 1 2
GS 4 b/f 47 1p 4 1 1 0 2
gs 6 b/m 69 1p 2a 1 2
gs 1 b/m 63 1p 2b 0 1 1 2
JH 118 w/m 53 1p 1a 1 1 1 2
JH 24 b/f 73 0 2a 1 1 0 3
JH 25 w/m 55 0 1a 0 1 0 3
JH 28 w/m 36 0 2b 0 0 0 3
JH 39 b/m 48 0 2a 0 0 0 3
JH 45 w/m 59 0 1a 1 0 0 3
JH 57 u/f 80 0 1a 1 0 0 3
JH 58 w/m 66 0 1b 1 0 0 3
JH 59 b/f 47 0 1b 1 0 0 3
JH 62 w/m 83 0 1a 0 1 0 3
JH 76 w/m 51 0 1a 1 0 0 3
JH 91 w/f 56 0 4 0 0 0 3
JH1 03 w/f 60 0 2a 1 0 0 3
JH 107 w/f 83 0 2a 0 1 0 3
JH 140 a/f 76 0 1b 0 0 0 3
JH 169 b/m 43 0 5 0 0 0 3
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Pat gend/race age event disease B-blocker antiarrhy. valid group
jh 195 w/f 70 0 1a 0 0 1 3
gs 28 w/m 79 0 1a 0 1 1 3
jh 198 w/m 56 0 1a 0 0 1 3
jh 171 b/f 42 0 1a 1 0 1 3
jh 165 o/m 38 0 1a 1 0 1 3
jh 151 w/m 65 0 1a 0 0 1 3
jh 144 b/m 23 0 2b 1 0 1 3
JH 119 w/m 40 0 1a 0 0 1 3
JH 117 w/m 71 0 1a 1 0 1 3
JH 111 w/f 45 0 1a 0 1 1 3
JH 94 w/f 73 0 1a 0 1 1 3
JH 86 b/m 55 0 2a 1 0 1 3
JH 72 b/f 65 0 1b 1 0 1 3
JH 51 w/m 56 0 1a 1 1 1 3
JH 47 w/m 64 0 1b 0 0 1 3
JH 23 a/f 60 0 1a 1 0 1 3
jh 190 b/m 68 0 1a 1 1 1 3
JH 45 w/m 59 0 1a 1 1 1 3
JH 93 b/m 37 0 2b 1 1 1 3
JH 98 w/m 66 0 2a 1 0 1 3
JH 122 w/f 78 0 1b 1 1 1 3
JH 124 w/f 65 0 1a 1 1 1 3
Table B1: Details of the database used in this thesis. See Tab. B2 for description
of the codes.
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Code Explanation
Disease
1a CAD+AMI
1b CAD+Angina Pectoris
1c CAD+OMI
2a Ischemic Dilated Cardiomyopathy
2b Non-ischemic Dilated Cardiomyopathy
2c Hypertrophic Carediomyopathy
3 Valve Disease
4 Primary Electrophysiological Event
5 Unknown
Rhythm
0 No arrhythmia
1m NSVT (< 30 sec) , monomorphic
1p NSVT, poly
2m Sustained VT, monomorphic
2p Sustained VT, polymorphic
3 VF
4 Arrest
5 Other
Group
1 Sustained VT/VF
2 Non sustained VT/VF
3 Control
Race/Gender
w White
b African American
a Asian
o Other
u Unknown
m Male
f Female
Table B2: Codes of the Tab. B1. CAD=coronary artery disease, AMI=acute
myocardial infarction, OMI=oclusive myocardial infarction, NSVT=non sustained
ventricular tachycardia, VT=ventricular tachycardia, VF=ventricular brillation.
